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Abstract
Large scale clinical trials and population based research studies collect huge amounts of neuroimaging data.
Machine learning classifiers can potentially use these data to train models that diagnose brain related diseases
from individual brain scans. In this dissertation we address two distinct challenges that beset a wider adoption
of these tools for diagnostic purposes.
The first challenge that besets the neuroimaging based disease classification is the lack of a statistical inference
machinery for highlighting brain regions that contribute significantly to the classifier decisions. In this
dissertation, we address this challenge by developing an analytic framework for interpreting support vector
machine (SVM) models used for neuroimaging based diagnosis of psychiatric disease. To do this we first note
that permutation testing using SVM model components provides a reliable inference mechanism for model
interpretation. Then we derive our analysis framework by showing that under certain assumptions, the
permutation based null distributions associated with SVM model components can be approximated
analytically using the data themselves. Inference based on these analytic null distributions is validated on real
and simulated data. p-Values computed from our analysis can accurately identify anatomical features that
differentiate groups used for classifier training. Since the majority of clinical and research communities are
trained in understanding statistical p-values rather than machine learning techniques like the SVM, we hope
that this work will lead to a better understanding SVM classifiers and motivate a wider adoption of SVM
models for image based diagnosis of psychiatric disease.
A second deficiency of learning based neuroimaging diagnostics is that they implicitly assume that, `a single
homogeneous pattern of brain changes drives population wide phenotypic differences'. In reality it is more
likely that multiple patterns of brain deficits drive the complexities observed in the clinical presentation of
most diseases. Understanding this heterogeneity may allow us to build better classifiers for identifying such
diseases from individual brain scans. However, analytic tools to explore this heterogeneity are missing. With
this in view, we present in this dissertation, a framework for exploring disease heterogeneity using population
neuroimaging data. The approach we present first computes difference images by comparing matched cases
and controls and then clusters these differences. The cluster centers define a set of deficit patterns that
differentiates the two groups. By allowing for more than one pattern of difference between two populations,
our framework makes a radical departure from traditional tools used for neuroimaging group analyses. We
hope that this leads to a better understanding of the processes that lead to disease and also that it ultimately
leads to improved image based disease classifiers.
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ABSTRACT
CONVERTING NEUROIMAGING BIG DATA TO INFORMATION: STATISTICAL
FRAMEWORKS FOR INTERPRETATION OF IMAGE DRIVEN BIOMARKERS AND
IMAGE DRIVEN DISEASE SUBTYPING
Bilwaj Gaonkar
Christos Davatzikos, Ph.D.
Large scale clinical trials and population based research studies collect huge amounts of
neuroimaging data. Machine learning classifiers can potentially use these data to train
models that diagnose brain related diseases from individual brain scans. In this dissertation
we address two distinct challenges that beset a wider adoption of these tools for diagnostic
purposes.
The first challenge that besets the neuroimaging based disease classification is the lack of
a statistical inference machinery for highlighting brain regions that contribute significantly
to the classifier decisions. In this dissertation, we address this challenge by developing an
analytic framework for interpreting support vector machine (SVM) models used for neu-
roimaging based diagnosis of psychiatric disease. To do this we first note that permutation
testing using SVM model components provides a reliable inference mechanism for model
interpretation. Then we derive our analysis framework by showing that under certain
assumptions, the permutation based null distributions associated with SVM model compo-
nents can be approximated analytically using the data themselves. Inference based on these
analytic null distributions is validated on real and simulated data. p-Values computed from
our analysis can accurately identify anatomical features that differentiate groups used for
classifier training. Since the majority of clinical and research communities are trained in
understanding statistical p-values rather than machine learning techniques like the SVM,
we hope that this work will lead to a better understanding SVM classifiers and motivate a
vi
wider adoption of SVM models for image based diagnosis of psychiatric disease.
A second deficiency of learning based neuroimaging diagnostics is that they implicitly as-
sume that, ‘a single homogeneous pattern of brain changes drives population wide pheno-
typic differences’. In reality it is more likely that multiple patterns of brain deficits drive
the complexities observed in the clinical presentation of most diseases. Understanding this
heterogeneity may allow us to build better classifiers for identifying such diseases from indi-
vidual brain scans. However, analytic tools to explore this heterogeneity are missing. With
this in view, we present in this dissertation, a framework for exploring disease heterogeneity
using population neuroimaging data. The approach we present first computes difference
images by comparing matched cases and controls and then clusters these differences. The
cluster centers define a set of deficit patterns that differentiates the two groups. By allowing
for more than one pattern of difference between two populations, our framework makes a
radical departure from traditional tools used for neuroimaging group analyses. We hope
that this leads to a better understanding of the processes that lead to disease and also that
it ultimately leads to improved image based disease classifiers.
vii
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CHAPTER 1
Introduction
1.1. Background
Over the past few decades, there has been spectacular advancement in medical image ac-
quisition technology. Due to the reduction in cost and improved scanning techniques there
has been an explosive growth in the availability of in vivo neuroimaging data. This growth
has lead to the collection of vast amounts of neuroimaging data by several different re-
search groups and consortia around the world. Some of the examples include the Batimore
longitudinal study of Aging or BLSA (Kawas et al., 1997), the Philadelphia neurodevelop-
mental cohort or PNC (Satterthwaite et al., 2014), the Alzheimer’s Disease Neuroimaging
Initiative or ADNI (Jack et al., 2008) and the Enhancing NeuroImaging Genetics through
Meta-Analysis or ENIGMA (Thompson et al., 2014) cohorts. However, these are by no
means unique. Several different groups, laboratories and consortia, across the world are
collecting similar datasets in an attempt to better understand the structure and function
of the living human brain. As such, each of these studies generates massive amounts of
neuroimaging data.
Understanding the structure and function of the human brain using these massive neuro
imaging data sets presents a fundamental challenge to existing traditional statistical analysis
techniques. Each brain image contains an extremely large number of pixels/voxels. Relative
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to the total number of voxels in an image, the total number of brain images in a given data
set is always small. Thus, the dimensionality of the data, as measured by number of voxels
per image, is far higher than the sample size, as measured by total number of images in
the study. Traditional statistical techniques are mostly designed to analyze and visualize
with the low dimension high sample size data. Hence analysis of high dimension low sample
size data, such as the data generated by large scale neuroimaging studies, requires the
development of fundamentally new statistical methodologies themselves.
Thus, the development of novel statistical analysis methodologies geared towards large scale
neuroimaging studies is the primary topic of this thesis. Next, we present a short summary
of the different technologies that must be understood before delving into the main topic of
this work. While each of these technologies may themselves be considered an active topic of
research, for the purposes of this thesis we utilize standard implementations that are peer
reviewed and accepted by the medical image analysis community at large.
1.2. Key technologies for comparing images across pop-
ulations
Brain imaging data as obtained from the scanner can come from one of many modalities.
Further most of the raw data obtained from the scanner cannot be directly used for pop-
ulation wide statistical analysis. Depending on the modality and the quality of the data
a sufficient degree of image pre-processing is necessary before delving into group compar-
isons. In this section we describe some of the common medical imaging modalities as well
as commonly used preprocessing steps.
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1.2.1. Medical imaging modalities
A diverse array of medical imaging modalities were developed in the last few decades of the
twentieth century. We cannot describe the details of every single medical imaging modality
out there in this thesis. As such design of imaging protocols in itself is still an active area
of research. Nevertheless, we present a brief description of some of the more commonly
used modalities in the appendix. One may broadly categorize medical image modalities
as structural and functional. Structural imaging modalities such as T1-weighted MRI, T2-
weighted MRI, FLAIR MRI, CT and diffusion tensor MRI (DTI) reveal anatomical aspects
of the organ under study. Functional imaging modalities are measure temporally dynamic
changes in tissue. Examples of such modalities include BOLD fMRI, contrast enhanced T1
MRI and PET. We have briefly described each of these modalities in the appendic. The
work presented in this thesis contains experiments using T1-weighted MRI and BOLD-fMRI
images. However, the methods presented are applicable to imaging data as well as other
high dimensional data.
1.2.2. Image preprocessing
Image pre-processing is necessary step before imaging data can be used for group analysis.
The exact nature and number of steps that may be required before the application of a
specific algorithm may vary depending on the algorithm itself, the modality under study
and the anatomy. Work presented here primarily deals with brain imaging data. Hence, we
limit ourselves to brain imaging studies. In the appendix we present a brief description of
preprocessing steps used to generate the data used in the thesis.
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1.3. The evolution of population based neuroimaging
analysis
With the widespread availability of various image acquisition technologies and standardiza-
tion of acquisition and pre-processing protocols, it has become possible to collect neuroimag-
ing data from entire populations. This has lead to several large scale neuroimaging studies
targeted at comparing clinically abnormal populations to normal controls. The images in-
volved are most often structural or functional MR scans. But they may be any other types
of imaging data, including but not limited to contrast maps, connectivity maps or some
measures derived from other more advanced imaging modalities. In either case, detection
and description of imaging differences driving the clinical distinction between populations
remains the central question of population neuroimaging. The sheer dimensionality of these
data pose a challenge to traditional statistical analysis techniques. This has lead to the de-
velopment of several methods attempting to address this challenge. The work presented in
this thesis also addresses this problem. In order to place our work in context of current
literature we present a review of prior art in this section.
1.4. Univariate morphometric methodologies
Given imaging data associated with two clinically different populations (eg. patients and
controls) or with two functional conditions (eg. activation and baseline), the simplest
question one may ask is, ”Which brain regions differ between the two groups?” . Naturally,
this lead to the development of a whole set of methods directed at addressing this question.
We describe these methods next.
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1.4.1. Region based morphometry
Traditional neuroscience dictates that specific anatomical structures in the brain are asso-
ciated with specific functions. Thus, the first attempts at population based neuroimaging
analyses worked off similar hypotheses. These approaches are collectively referred to as
region of interest (ROI) based morphometry. In ROI based morphometric analysis, the
volume of the whole brain or its subparts is measured by drawing regions of interest (ROIs)
on brain images. The volumes of these regions are compared between subjects or across
populations. (Giedd et al., 1996; Ge et al., 2002; Giedd et al., 1996) However, this is time
consuming and can only provide measures of rather large areas. Smaller differences in vol-
ume may be overlooked and there is always the possibility of errors due to inconsistencies
between manual segmentations of ROIs. Further, there exists substantial inter rater vari-
ability in the manual definition of ROIs. This makes reproducibility difficult. Thus, region
based morphometric analysis was eventually superseded by other fully automated methods
of analyzing population neuroimaging data.
1.4.2. Deformation based morphometry
Deformtion based morphometry (DBM)(Chung et al., 2001; Gaser et al., 1999; Cao et al.,
1999) relies upon directly comparing two or more deformation fields using multivariate
statistical tools such as the Hotelling’s T 2 test. As such, this constitutes a voxel wise mor-
phometric method. These methods as a whole and DBM in particular do not require apriori
knowledge of the ROI to perform analysis. This has certain advantages in terms of being
able to detect local structures. For instance, DBM can detect exactly what part of a par-
ticular ROI is responsible for most of the anatomical variation within a group. Thus, DBM
has certain advantages over traditional ROI based approaches. However, one of the prob-
lems with comparing deformation vectors in a voxel wise fashion is that these measurements
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incorporate translation in addition to growth. In the context of group difference analysis
or the study of temporal variation in brain morphology, we are often more interested in
increase/decrease in local volumes rather than displacements themselves. Since DBM aims
to measure the relative position of two voxels before and after deformation, rather than
volume changes, it provides a relatively indirect measure of volume changes. This lead to
the evolution of tensor based morphometry, which looks at the Jacobian of the deformation
field instead of the field itself. We describe this next.
1.4.3. Tensor based morphometry
Tensor based morphometry (TBM) uses is another voxel wise morphometric technique that
uses the spatial derivatives of deformation fields instead of using the raw field displacements
themselves. Since TBM is also a voxel wise technique it does not require apriori segmen-
tation of regions of interest. It inherits the other big advantage of DBM as well, which is
the ability to detect localized changes not detectable using anatomical landmarks or ROIs.
Several tensorial measures may be constructed from the derivatives of deformation fields but
perhaps the most interesting, and the most widely used is the Jacobian of the deformation
field and it’s determinant. If we assume u(x) ∈ R3 to be the three dimensional deformation
vector associated with the point x ∈ R3 in template space, then the Jacobian is a tensor
that may be defined as:
J(x) =

∂u1
∂x1
∂u1
∂x2
∂u1
∂x3
∂u2
∂x1
∂u2
∂x2
∂u2
∂x3
∂u3
∂x1
∂u3
∂x2
∂u3
∂x3

The nine components of this tensor may be used to measure morphological variability. The
determinant of the Jacobian measures expansion or shrinkage of an infinitesimal volume el-
ement as it is deformed from the subject space to the template space. Thus, by comparing
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Jacobian determinants across subjects we obtain a localized measure of volumetric variabil-
ity of brain tissue across a population. This is the essence of tensor based morphometry.
(Davatzikos et al., 1996; Thompson and Toga, 1998). Other tensorial measures that may
be constructed for use with tensor based morphometry include but are not limited to the
the strain and vorticity tensors (Chung, 2013). Any number of tensorial measures may be
constructed from first or higher order derivatives of deformation fields. Each measure may
be associated with a specific type of measurement. Any method that uses such measures
to quantify morphological differences between groups may be considered under the title of
tensor based morphometry.
1.4.4. Voxel based morphometry
In a loose sense the term voxel based analyses may refer to all methods that depend upon
voxel wise comparison of neuroimaging based measurements. In this sense both deformation
based and tensor based morphometric analyses are voxel based analyses. However, specifi-
cally voxel based morphometry refers to the voxel wise comparison of local concentrations of
gray and white matters across populations (Davatzikos et al., 2001; Ashburner and Friston,
2000). The main advantage of using tissue density maps is that they are relatively robust to
small registration errors. This is different from DBM or TBM, both of which rely on highly
accurate registration of one brain to another. Given the tremendous anatomical variation
of the human brain, perfect registration is almost always impossible. As described before,
tissue density maps are robust to small registration errors since they are generated using
a discrete approach. In a certain sense they are the discretized version of the Jacobian
determinant described in the previous subsection. Because of the discrete approach forces
local volume preservation between subject image and the tissue density map is essentially
guaranteed even in the presence of registration errors. This cannot be said of the Jacobian
determinant which relies purely on the deformation field. This is the reason voxel based
morphometry is perhaps the most popular method in population neuroimaging analysis.
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1.5. Multivariate morphometry: Machine learning in com-
putational neuro-anatomy
A common feature of all the methods presented in the previous section is that they per-
form statistical analyses on a voxel by voxel basis. Thus, these methods cannot highlight
multi-voxel patterns of imaging differences that may drive population stratification. Fur-
ther this type of statistical analysis offers almost no value in terms of predictive analyses.
That is, finding differences between two populations using any one of the above approaches
does not rigorously quantify how well imaging may be used for diagnostic or prognostic
purposes. Such predictive analytics are very important from a clinical perspective. Both
these shortcomings lead to the development of machine learning based multivariate analysis
techniques. In this section we present some background on how machine learning based
analysis is typically applied in population neuroimaging. We elaborate in the following
sections.
1.5.1. Supervised models
In machine learning theory, supervised learning constitutes a set of algorithms that reason
from externally supplied instances (training data) to produce general hypotheses, which
then make predictions about future instances (test data). Supervised learning makes the
assumption that the probability distributions associated with training and testing data
are identical. Supervised learning methods are perhaps the most widely applied machine
learning algorithms in biological data analysis. In the context of medical imaging several
authors have applied supervised machine learning techniques to make disease diagnosis from
imaging data. While the exact analysis pipelines used for generating MRI-based diagnostic
models using machine learning are quite varied they generally include the following steps:
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1. Collecting a training data set: The objective of this step is to acquire a sufficiently large
number of brain image scans from clinically well characterized subjects. Clinical properties
used in defining subject categories may include diagnoses, pathological measures or even
test scores, which can be used as the gold standard for the classification problem. However,
it should be remembered that these definitions form the ‘gold standard’ which will be used
by the classification algorithm for learning a model of the disease in the subsequent stages.
2. Feature extraction from raw imaging data: Just like the statistical morphometric tech-
niques described in the previous section of this chapter, learning using standard machine
learning tools requires that imaging data be pre-processed to be comparable across pop-
ulations. As described earlier, several different registration based measures may be used
for this purpose. In the case of structural MRI imaging data we use tissue density maps
for machine learning algorithms throughout this thesis. The relevant tissue density map is
obtained by pre-processing image informations from the required tissue type (Davatzikos
et al., 2001). The map is then vectorized to obtain a feature vector that is used by stan-
dard machine learning techniques. Thus, in this thesis, features refer to individual voxel
intensities in the RAVENS map images and each feature vector represents an entire image.
3. Dimensionality reduction and feature selection: Most of the data generated by neu-
roimaging studies contains at best a few hundred samples. However, the image associated
with each sample is constituted of millions of voxels. Thus, one can view the dataset as
a collection of a few hundred points in a space which has at least a million dimensions.
The dimensionality can thwart any effort to estimate the distribution of such a point cloud
using standard probablistic modeling techniques. Thus, several authors suggest reducing
the dimensionality using one of several dimensionality reduction techniques. Such reduction
inevitably causes some loss of signal. However, if a dimensionality reduction technique can
effect a a greater reduction in the ‘noise’ of inter subject variability, then there is a potential
payoff in increased classification accuracy.
4. Model training and optimization: The classifier uses the training data and the known
9
labels to learn a rule to separate the classes. Several classification algorithms may be used
in this step. One of the most widely used method for diagnosis of neuropsychiatric disease
using imaging data is the support vector machine (SVM). (Boser et al., 1992; Vapnik and
Vapnik, 1998; Burges, 1998). The maximum margin formulation of the SVM algorithm
generalizes well to high dimensional spaces. Hence, the SVM is capable of learning using
high dimension low sample size (HDLSS) data of neuroimaging. Other algorithms that have
been used for neuroimaging based classification include the relevance vector machine (RVM),
neural networks and regularized linear discriminant analysis. Regardless of the choice of
algorithm, there always exist a set of parameters than need to be tuned to fit the model
to the data. The most common way of tuning these parameters is cross-validation. N-fold
cross-validation involves randomly dividing the entire training data set into N subgroups
and then training the algorithm with specific parameters on N-1 subgroups and testing on
the left-out subgroup. This process is repeated by leaving each of the sub-groups out one at
a time and estimating the average error over all the runs. The model (or the parameters)
that gives the best accuracy is picked as the final model.
5. Application to test data: The final step in a typical supervised machine learnng pipeline
is to apply the learned rule to a completely new data set that has been pre-processed
exactly like the training data set. Effectively, this amounts to testing the generalizability
of the model fitted in step 4 onto new data. Sometimes independent data may not be
available due to limited sample sizes for testing and training. In such cases cross validation
alone may be used to estimate model performance. However, it is important to distinguish
between cross validation used for tuning the model and cross validation used for evaluating
it. Model selection should be done using an inner cross validation loop while test accuracies
are evaluated using an outer loop. Regardless of cross validation, the best approach is to
test the trained model using an independent, hitherto unused test dataset.
Supervised classification technology has been used in for the diagnosis of several different
diseases from brain images. Several authors have used supervised classification to diagnose
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Alzheimer’s disease from neuroimaging data. (Klöppel et al., 2008b; Davatzikos et al.,
2011; Fan et al., 2007; Filipovych et al., 2012; Gaonkar and Davatzikos, 2013; Varol et al.,
2012) A detailed review of the work on supervised classification of Alzheimer’s disease is
presented in (Cuingnet et al., 2011). Several authors have applied supervised classification
to the diagnosis of schizophrenia and psychosis (Sun et al., 2009; Ho et al., 2011; Kawasaki
et al., 2007; Koutsouleris et al., 2009). Other authors have applied this technology for
developing imaging based biomarkers for autism (Ecker et al., 2010; Jiao et al., 2010),
Huntingdon’s disease (Klöppel et al., 2008a), Parkinson’s disease.(Das, 2010) and fronto
temporal dementia (Davatzikos et al., 2008).
1.5.2. Unsupervised and semi supervised models
The second major thrust of machine learning is the development of unsupervised learning
methods. The key difference between supervised and unsupervised learning is the absence
of excplicitly defined labels. Unsupervised learning focuses on uncovering latent structure
in the data through the application of appropriate algorithms. The neuroimaging commu-
nity has widely adopted unsupervised machine learning methods in the analysis of resting
state functional imaging data. For instance independent components analysis and its myr-
iad variants have been successfully used to tease out functional brain networks from data
(Calhoun et al., 2001; McKeown et al., 1997; McKeown, 2000). Typical application of these
types of learning methods includes:
1. Collecting the dataset. As in the supervised case, the objective of this step is to obtain
a large set of brain images. However, unlike the supervised case these images may not
correspond to groups of individuals with specific phenotypic characteristics.
2. Feature extraction and dimensionality reduction. As in supervised learning, feature
extraction is an important aspect of unsupervised methods. Raw imaging data needs to
be adequately pre-processed to ensure feature correspondences and a relatively noise free
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dataset. Dimensionality reduction may be done if it is found to increase the signal to noise
ratio.
3. Unsupervised analysis. Finally, one may apply the chosen method of unsupervised data
analysis, to the processed data. In the case of independent components analysis applied to
fMRI data, the analysis produces a set of ‘independent component’ images that are thought
to correspond to resting state functional brain networks. Clustering of raw imaging data
can yield insights into anatomical variation amongst individuals in a population.
In general, the objectives of unsupervised analysis tend to be more exploratory than dis-
criminative. Perhaps this explains the limited application of unsupervised analysis to the
exploration of disease effects or population wide differences. However, we believe that
application of the unsupervised learning paradigm to explore population wide group differ-
ences represents a hitherto untapped opportunity that has the potential to generate several
exciting insights. We explore this possibility in this dissertation.
1.6. Key challenges in using machine learning for com-
putational neuroanatomy
While the application of machine learning techniques, both supervised and unsupervised
presents an unprecedented opportunity for gaining insights from large neuroimaging data,
it also presents substantial challenges. In this section we outline these challenges. In
the following section we briefly discuss how this dissertation addresses some of these key
challenges.
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1.6.1. High dimensionality and low sample size
Brain images typically contain a large number of voxels. The number of non zero vox-
els in a typical T1- MR scan of the brain numbers in the hundreds of thousands, even
when the image is downsampled and pre-processed. With improvements in scanner tech-
nology this number has been increasing continuously. On the other hand most population
based neuroimaging studies of disease process will scan, at most a thousand individuals.
A large majority of studies collect fewer than a hundred scans including patients and con-
trols. Consequently, the majority of neuroimaging datasets that may be used for supervised
or unsupervised machine learning analyses are beset by a situation where the number of
measurements per sample (that is, the number of voxels) far outstrips the total number of
samples in the study. In machine learning parlance this is known as the high dimension low
sample size problem. Since the majority of theoretical developments in machine learning
and statistics focus on data with high sample size and low dimensionality , the properties
of high dimensionality are often poorly understood (Clarke et al., 2008).
The support vector machine algorithm is a specialized technique that has been found to
outperform competing approaches in the high dimension low sample size setting (Statnikov
et al., 2008). The support vector machine (SVM) is a powerful binary classifier rooted in
statistical learning theory that can theoretically achieve a global optimum solution (convex
optimization) and bypass the curse of dimensionality through the use of a maximum margin
criterion for classification (Clarke et al., 2008; Statnikov et al., 2008; Jain et al., 2000). The
SVM provides a way to control model complexity independent of dimensionality and offers
the possibility to construct generalized, non-linear predictors in high-dimensional spaces
using a small training set (Jain et al., 2000; Clarke et al., 2008).
Hence, it is ideal for use in the neuroimaging setting. Indeed several authors have used the
SVM for creating diagnostic imaging based biomarkers (Klöppel et al., 2008b; Davatzikos
et al., 2011; Fan et al., 2007; Filipovych et al., 2012; Gaonkar and Davatzikos, 2013; Varol
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et al., 2012). Thus, this dissertation addresses the problem of interpreting of support vector
machine models used in neuroimaging analysis.
1.6.2. Lack of interpretability of supervised models
While SVMs have been successfully used to create neuroimaging based biomarkers, they
have typically been regarded as blackboxes. The question of interpretability of SVM models
has received substantially lesser attention in neuroimaging literature, as compared to their
application for biomarker development. Yet, it is extremely important to understand in a
mathematically rigorous fashion : What voxels/regions does a particular supervised model
of disease rely upon to make predictions/diagnoses? Answering this question is imperative
from the point of view of understanding the physiological basis on which classifier predic-
tions are based. It is only recently that this question is being looked at in neuroimaging
literature. In this thesis we develop and validate a mathematically rigorous p-value based
analytical approach to interpret support vector machine models used in neuroimaging. Un-
like competing approaches which produce somewhat arbitrary weight values or supervoxels
our approach produces a p-value map similar to that produced by VBM or TBM. That
is we create a p-value map indicating which brain regions contribute significantly to the
classification. The p-value is a well defined, well understood in multiple communities and
a mathematically rigorous way to quantify statistical significance. Thus, it is naturally
advantageous to interpret SVM models in terms of p-values as opposed to weights or super-
voxels. Further, the p-value maps produced by our method can detect multivariate effects
in the data and present an advantage over the regular VBM or TBM in terms of morpho-
metric analysis. The next two chapters of this thesis describe in detail this framework for
interpreting diagnostic SVM models used in neuroimaging analysis.
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1.6.3. Insensititivity to heterogeneity
SVMs and other supervised learning approaches lead to powerful image based diagnos-
tics However, the driving philosophy behind the majority of such analyses is that a single
imaging pattern can distinguish between phenotypically distinct populations. However, dis-
eases like schizophrenia and autism, are known to be clinically heterogeneous. For instance
schizophrenia can be subdivided based on its symptomatic presentation into positive and
negative subtypes (Andreasen and Olsen, 1982); autism spectrum disorders present no clear
pattern of brain deficits due to heterogeneity (Amaral et al., 2008) and even Alzheimer’s
disease may be divided into distinct subtypes (Rabinovici et al., 2008). Given the com-
plexity of the human brain, the subjectivity of clinical scoring, and the ample evidence for
heterogeneity in behavioral symptomatology, it is likely that multiple sub-types/patterns
of brain changes are associated with a particular population wide phenotypic/clinical dif-
ferentiation, such as a disease or a dimension of cognitive impairment. Thus, image driven
SVM classifiers, which make the single pattern assumption cannot match the diagnostic
capabilities of clinicians. Humans combine a large number of observed facts to make a
decision, wheareas the only data that the SVM has is an image. Thus, it is likely that
the failure of SVM based imaging biomarkers is at least in part driven by the fact that;
what is generally defined as a single disease by humans, is in fact the manifestation of sev-
eral distinct pathological processes. Automated diagnostics aside, there do not even exist
tools to explore such heterogeneity using imaging data. This is because population based
image analysis tools like VBM are also based on the assumption that a single pattern of
brain deficits drive pathology. While this assumption is convenient, it misses the tremen-
dous opportunity that imaging data offer for objectively disentangling disease heterogeneity.
Heterogeneity, as defined for the purposes of this dissertation, refers to the existence of sub-
populations of patients that are clinically distinct. The aim of imaging based heterogeneity
analysis is to identify the subpopulation structure by identifying distinct patterns of brain
deficit associated with each subpopulation.
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A data driven exploration of disease heterogeneity has the potential to improve not only bio-
markers but also fundamentally advance our knowledge of the disease process itself. Thus,
in this dissertation we address this we develop an algorithm for image driven exploration
of disease heterogeneity. Our technique constitutes an application of unsupervised machine
learning analysis and generates clinically relevant sub-types of disease using a data driven
approach.
1.7. Addressing the challenges : Structure of the thesis
In this section we highlight how each chapter of this dissertation addresses the challenges
presented above. In doing so we also present an overview of the work presented in each
chapter.
1.7.1. Chapter 2
Material presented in the next chapter directly addresses the challenge of interpreting SVM
models used in neuroimaging analysis using a statistical p-value based framework. As de-
scribed earlier, SVM models have shown great promise for population based pattern analysis
and classification of neuropsychiatric diseases. The interpretation of SVM models can allow
us to 1) understand the basis of classifier decisions and 2) highlight the combination of brain
regions used by the SVM to make a diagnostic/prognostic decision. The p-values produced
by our model provide a multivariate alternative to the standard mass univariate methods
used for making population wide statistical comparisons between using brain images. As
such, voxel based analysis and related methods, cannot detect multivariate patterns associ-
ated with group differences while the SVM based morphometric formulation from chapter 2
can. We develop our theoretical framework as an asymptotic approximation of the permu-
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tation testing procedure applied on SVM weight vector components. Ultimately, this yields
an inference machinery that operates by comparing components of SVM weight components
to normal distributions whose variances can be computed analytically from the data.
1.7.2. Chapter 3
The formulation developed in chapter 2 produces p-values that can detect univariate as well
as multivariate effects. However, it ignores a fundamental facet of SVM theory; namely
the SVM margin. Consequently, the use of this framework for interpreting SVM models
or for morphometric analysis leads to extremely conservative inference. We address this
deficiency in chapter 3 by further developing the theory presented in chapter 2 to with
incorporation of the SVM margin. Specifically, we develop a statistic that explicitly accounts
for the SVM margin. Further, we show that null distributions associated with this statistic
are also asymptotically normal. We delineate the advantages of using this margin based
statistic for interpreting SVM models. Our experiments show that this statistic is a lot
less conservative as compared to weight based permutation tests and also less sensitive to
variation in the extent of imaging differences between groups being studied. Ultimately,
this new statistic enables us to better understand the multivariate patterns that the SVMs
uses for neuroimaging based classification. Chapters 2 and 3 mainly address the challenge
of interpreting SVM models used for neuroimaging based diagnostics.
1.7.3. Chapter 4
While chapters 2 and 3 focus on interpreting supervised machine learning models, chapter 4;
explicitly deals with the challenge of imaging based exploration of disease heterogeneity. As
opposed to chapters 2 and 3, which are interpretative, the analytic frameworks presented
in chapter 4 are exploratory. While chapters 2/3 are based on the assumption that a
17
single pattern of imaging deficit drives the clinical difference between cases and controls,
the analyses presented in this chapter allows for the existence of multiple such patterns of
deficit. Thus, it explicitly accounts for the presence of heterogeneity in the definition of
neuropsychiatric disease. Given the complexity of the human brain and the subjectivity of
clinical scoring; it is likely that multiple different patterns of imaging deficit drive specific
population wide phenotypic differences. Theoretical developments in this chapter utilize
unsupervised machine learning analyses to define case sub-populations using imaging data.
The proposed approach can highlight imaging patterns present only in sub populations of
a group of cases rather than a ‘common denominator’ pattern of difference between cases
and controls.
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CHAPTER 2
Interpreting supervised learning
models : An analytic inference
framework that approximates
permutation testing for SVM
classifiers used in neuroimaging
2.1. Introduction
With the availability of cheap computational power and the execution of large population
wide neuroimaging studies, it became feasible to attempt the development of imaging based
diagnostics for neurologic and neuropsychiatric disorders. However, diagnoses of such dis-
orders from brain images is distinct from traditional radiology. While traditional radiologic
diagnostics rely on relatively localized intensity and spatial abnormalities in the brain (eg.
a tumor or a stroke), the imaging signatures of neuropsychiatric disorders tend to be far
more subtle. Typically, neuropsychiatric diseases are characterized by a combination of
morphological and functional differences in several different regions of the brain. Machine
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learning tools can ‘learn’ these complex multivariate patterns of imaging abnormalities from
large imaging data-sets and then use them for imaging based diagnosis. The potential for
creation of individualized imaging based diagnostic and prognostic biomarkers for neuropsy-
chiatric disorders has led to a tremendous amount of attention being directed to supervised
machine learning analysis in the neuroimaging literature over the past decade. However, de-
velopment of imaging based diagnostics has been challenging because, neuroimaging studies
collect a relatively small number of samples, typically in the hundreds and rarely above 1000
and yet each image is constituted of millions of voxels. Thus, neuroimaging data are ‘high
dimensional with low sample size’. Most learning techniques are designed to operate in the
setting where number of samples far outstrips the number of measurements. However, some
algorithms like the support vector machine (SVM) have been shown to operate effectively
in the high dimension low sample size domain (Clarke et al., 2008). This is perhaps why,
this is the most widely used algorithm for developing neuroimaging based diagnostics. How-
ever, interpretation of support vector machine models in terms of well understood statistical
paradigms such as p-values has remained a key challenge. Addressing this challenge is the
thrust of this chapter. With this objective, we describe the SVM algorithm in the next
section.
2.2. The key challenge: Interpreting support vector ma-
chines (SVM) classification models in classification
The support vector machine (SVM) is a powerful binary classifier rooted in statistical
learning theory that can theoretically achieve a global optimum solution (convex optimiza-
tion) and bypass the curse of dimensionality (Clarke et al., 2008). The support vector
machine attempts to learn a model from data by finding the largest margin hyperplane
that separates data from different conditions (e.g. baseline/activation) or groups (e.g. pa-
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tients/controls)(see figure 1a). The process of finding this hyperplane using data with
known labels(condition, group, etc.) is known as training. Now if data with an unknown
label (test data) is presented, the hyperplane found by the SVM is used to estimate whether
it belongs to a patient or to a control. To apply SVMs, individual data are treated as points
located in a high dimensional space(see figure 1b). Figure 1c illustrates the concept of the
algorithm in an imaginary 2D space: dots and crosses represent imaging scans taken from
two groups or conditions. Even though the two groups cannot be separated on the basis
of values along any one dimension the combination of two dimensions gives perfect separa-
tion. This corresponds to the situation where a single anatomical region may not provide
the necessary discriminative power between groups, whereas the multivariate SVM can still
find the relevant hyperplane.
To apply SVMs in neuroimaging data, we convert an image with d voxels into a vector
whose jth component is equal to the measurement at the jth voxel in the pre-processed
image. Thus we re-organize the ith image into a d-dimensional point that lives in Rd. Let
us denote the ith point by xi where i ∈ 1, ....,m indexes all subjects in the study. In most
imaging studies we also have a label associated with each image which tells us whether the
image belongs to a patient or a control subject. We denote these labels by y(i) ∈ {+1,−1}.
Then the support vector machine finds ‘hyperplane coefficients’ denoted by w∗ and b∗ such
that:
{w∗, b∗} = argminw,b
1
2
||w||2 + C
m∑
i=1
ξi
suchthat. yi(w
Txi + b) ≥ 1− ξi ∀i = 1, ...,m
ξi ≥ 0 ∀i = 1, ...,m (2.1)
The ξi’s are slack variables that allows the learnt SVM model to be robust by allowing for a
small number of mis-classifications. The weight vector w∗ represents the SVM model. Since
the data x(i) are in the voxel space (one voxel per dimension), the weight vector w
∗ ∈ Rd is
an image. Because the classifier is multivariate by nature, the best combination of all dis-
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(a)
(b)
(c)
Figure 1: (a) The concept of imaging based diagnoses using SVMs (b) Images as points in
high dimensional space (c) The maximum margin principle of classification used in SVMs
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criminating voxels as a whole is identified by this weight vector based discriminative image.
These discriminative maps are multivariate. Understanding what regions are most relevant
to the classification/diagnosis rendered by the SVM, requires a statistical methodology to
interpret these maps. Since the maps are based on a multivariate classifier, popular uni-
variate methods (Ashburner and Friston, 2000) do not offer a direct solution. These maps
have several other desirable properties which typical univariate analysis does not provide
(Davatzikos, 2004). Until now the use of SVM based discriminative maps in neuroscience
has been limited because these maps do not directly answer a critical question “What is the
probability that a particular image voxel would have a weight vector component at least
as large as the one observed in an experiment due to pure chance alone?” To answer such
a question one needs to establish a null distribution on the weight vector components at
each image voxel. An empirical approach for obtaining such a null distribution is through
the use of permutation tests. We describe this permutation testing approach in the next
section.
2.3. Addressing the challenge: Permutation testing to
interpret SVM models
Permutation testing can be used to establish a null distribution on the weight vector com-
ponents at each image voxel. The permutation testing procedure is illustrated in figure 2.
In figure 2, the dots denote controls and the crosses denote patients. The first step involves
generation of a large number of shuffled instances of data labels by random permutations.
Each shuffled instance is used for training one SVM. This generates one hyperplane param-
eterized by the corresponding vector w, for each instance of shuffled labels. Thus, for a
particular component of w, we have a set of possible values. Each value in this set corre-
sponds to a specific shuffling of the labels. These values represent the empiricaly obtained
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null distribution of that component of w. Since each component of w corresponds to a spe-
cific voxel location in the original image space we now have a null distribution associated
with every voxel in the image space. Comparing each component of w∗ with the correspond-
ing null distribution allows us to estimate statistical significance. It is obvious that running
1000 permutation tests requires training 1000 support vector machine classifiers. This can
consume a considerable amount of computing time as well as memory and hard disk space.
Further 1000 permutations can allow for a p-value resolution of 0.001. If a lower resolution
is needed, for multiple comparisons correction analysis or for feature ranking with p-values,
a higher number of permutations are required. Even if one considers 10000 or a 100000
permutations the computational time and memory requirements can quickly become un-
feasible. To add to this complexity of population based neuroimaging studies often implies
that analysis be repeated, for different population subsets, different pre-processing settings
for with different data labeling and even with local 3D windows in the same image (Etzel
et al., 2013). Resource requirements for performing permutation testing for each of these
possible parameter setting in a neuroimaging study are very large and usually beyond the
capacity of even large imaging laboratories. In the future, ever increasing scanner resolu-
tions and sample sizes are likely to exacerbate these problems even further. In contrast to
SVM permutation analysis traditional univariate methods (Ashburner and Friston, 2000)
can run in a few minutes. This has lead to a much wider adoption of VBM as compared to
multivariate analysis despite known advantages of the latter. In order to address this issue,
in the following section, we present an analytic approximation of SVM permutation testing.
The analytic approximation we present can effectively generate p-value maps identical to
those produced by actual permutation tests without the computational overhead as long as
the data used are high dimensional with low sample sizes. The following sections detail our
approach.
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Figure 2: Illustration of the permutation testing procedure
2.4. Analytical framework approximating permutation
tests
The primary thrust of this chapter is to lay down an analytic framework for interpreting
SVM models. We do this by showing that the permutation testing procedure described
above can be replaced by an analytic framework based on the Gaussian distribution that
can be used to interpret SVM models in a small fraction of the time it takes for performing
the actual permutation tests. Our approximation is based on core support vector machine
theory and certain facts that empirically apply to high dimensional medical imaging data.
2.4.1. The case of balanced data
We begin with SVM models trained on datasets with equal numbers of positively and
negatively labeled samples.
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Figure 3: For most permutations the number of support vectors in the learnt model is
almost equal to the total number of samples (a) simulated dataset(b) real dataset with
Alzheimer’s patients and controls (c) real dataset with liars and truth tellers (d) the cancer
genome atlas gene expression data (e) the cancer genome atlas methylation data
We start by noting that VC-theory (Vapnik and Vapnik, 1998) dictates that linear classifiers
shatter high dimension low sample size data. For example, less than 3 non-collinear points
labeled using any combination of positive and negative labels can always be separated by
a line in 2D space. When the dimensionality is in the millions and the sample sizes are
in the hundreds one can always find ‘hyperplanes’ (the high dimensional analogue to lines)
that can separate any possible labelling of points. Thus, when using linear SVMs, for any
permutation of y, one can always find a separating hyperplane that perfectly separates the
training data. This allows us to use the hard margin support vector machine formulation
from (Vapnik and Vapnik, 1998) instead of (2.1) for further analysis in this chapter. The
hard margin support vector machine (see Vapnik and Vapnik (1998)) is written as:
minw,b
1
2
||w||2
subj.to. yi(w
Txi + b) ≥ 1
∀i ∈ {1, ....,m} (2.2)
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It is required (see Bishop (2007)) that for the ‘support vectors’, indexed by j ∈ {1, 2, .., nSV },
we have wTxj + b = yj ∀j. Now, if all our data were support vectors this would allow us
to write the constraints in optimization (2.2) as Xw + Jb = y where J is a column matrix
of ones and X is a super long matrix with each row representing one image. Since the labels
generated through random permutations, typically do not correspond to a fundamental
group difference that may be highlighted using imaging (or other types) of high dimensional
data, SVM models trained using randomly permuted labels tend to overfit. To overfit a
particular dataset, the model essentially stores all labels and data. That is, every sample is
treated as a support vector. We observed this behavior in medical imaging datasets as well
as genomic and epigenomic expression data that we investigated (figure 3). Accounting for
this behavior allows us the latitude of approximating SVM solutions for a majority of the
random permutations using a much simpler formulation. In fact for most permutations we
can solve the following simpler optimization instead of (2.2):
minw,b||w||2
subj.to. Xw + Jb = y (2.3)
The above formulation is exactly the same as an LS-SVM (Suykens and Vandewalle, 1999).
This equivalence between the SVM and LS-SVM for high dimensional low sample size data,
with random labeling, was also previously noted by (Ye and Xiong, 2007) where it was based
on observations about the distribution of such data as presented in (Hall et al., 2005). This
equivalence proves very useful because the LS-SVM, (2.3) can be solved in the closed form
(Suykens and Vandewalle, 1999). We show next how to derive the dual problem and solve
for dual variables ‘α’. One can use the method of Lagrange multipliers to solve (2.3). We
introduce the dual variables α ∈ Rm as is standard procedure to yield the Lagrangian:
L(w, b) = 1
2
||w||22 + αT (Xw + Jb− y) (2.4)
Setting ∂∂wL(w, b) = 0,
∂
∂bL(w, b) = 0 and
∂
∂αL(w, b) = 0, and solving for w yields the
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following system of equations:
∂L
∂w
= 0 → w = XTα, (2.5)
∂L
∂b
= 0 → JTα = 0, (2.6)
∂L
∂α
= 0 → y = Xw + Jb = XXTα + Jb (2.7)
This yields a system of simultaneous equations:
0 JT
J XXT

 b
α
 =
0
y
 (2.8)
Now note that we can compute:
0 JT
J XXT

−1
(2.9)
as being:
 (−JT (XXT)−1J)−1 − (−JT (XXT)−1J)−1 JT (XXT)−1
−(XXT)−1J
(
−JT (XXT)−1J
)−1
(XXT)−1 + (XXT)−1J
(
−JT (XXT)−1J
)−1
JT (XXT)−1

The inversion relies on the assumption that the kernel matrix XXT is invertible. We can
use this inverted form in order to solve for both α and b. Specifically, we can write the dual
variables α as:
α = [(XXT)−1 + (XXT)−1J(−JT(XXT)−1J)−1JT(XXT)−1]y (2.10)
These are the dual variables in our formulation. The expression for w then follows from
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the dual variables as:
w = XT[(XXT)−1 + (XXT)−1J(−JT(XXT)−1J)−1JT(XXT)−1]y = Cy (2.11)
where we have defined:
C = XT[(XXT)−1 + (XXT)−1J(−JT(XXT)−1J)−1JT(XXT)−1] (2.12)
Note that this expresses each component wj of w as a linear combination of yj ’s. Thus,
we can hypothesize about the probability distribution of the components of w, given the
distributions of yj . If we let yj attain any of the labels (either +1 or −1) with equal
probability, we have a Bernoulli like distribution on yj with E(yj) = 0 and V ar(yj) = 1
(the theory can be readily extended in the case of unequal priors). We first present the
theory from the point of view of equal priors and then present it for unequal priors. Since,
(2.11) expresses w as a linear combination of these yj we have:
E(wj) = 0 V ar(wj) =
m∑
i=1
C2ij (2.13)
where Cij are the components of the matrix C. Further, the variance of each component of
w, is controlled by the rows of the matrix C.Thus:
V ar(wj) =
m∑
i=1
C2ij (2.14)
These predicted variances agree well with variance estimates obtained from the actual per-
mutation testing (see figure 5). At this point, we have an analytical method to approximate
the mean and the variance of the null distributions of components wj of w (that would oth-
erwise be obtained using permutation testing). To uncover the probability density function
(pdf) of wj , we use the Lyapunov central limit theorem. We show that when the number
of subjects is large, the p.d.f of wj may be approximated by a normal distribution. To this
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end, from (2.13) and (2.12), we have:
wj =
m∑
i=1
Cijyi =
m∑
i=1
zji (2.15)
where we have defined a new random variable zji = Cijyi which is linearly dependent on yi.
We can infer the expectation and variance of zji from yj as:
E(zji ) = 0 = µi V ar(z
j
i ) = C
2
ij (2.16)
Thus, zji are independent but not identically distributed and wj are linear combinations of
zij . Then according to the Lyapunov central limit theorem(CLT) wj is distributed normally
if:
lim
m→∞
1[√∑m
i=1 V ar(z
j
i )
]2+δ m∑
k=1
E
[
|zjk − µk|
2+δ
]
= 0 for some δ > 0 (2.17)
As is standard practice we check for δ = 1.
E
[
|zjk − µk|
2+δ
]
= (1/2)|+ Ckj − 0|2+δ + (1/2)| − Ckj − 0|2+δ = C3kj (2.18)
Thus, we can write the limit in (2.17) as:
lim
m→∞
∑m
k=1C
3
kj[√∑m
i=1C
2
ij
]3 (2.19)
Now note that the binomial expansion of the denominator would contain cross terms that
are not a part of the numerator. Thus, in practice, this limit almost always goes to zero
and the the Lyapunov CLT applies. We present a more detailed analysis of a related limit
in the latter sections. When this limit is zero it allows us to approximate the distribution
of individual components of w using the normal distribution as:
wj
D−→ N (0,
m∑
i=1
C2ij). (2.20)
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These predicted distributions fit actual distributions obtained using permutation testing
very well (figure 5). Thus wj ’s computed by an SVM model using true labels can now
simply be compared to the distribution given by (2.20) and statistical inference can be
made. Thus, (2.20) ultimately gives us a fast and efficient analytical approach to interpret
SVM models using p-values based on the theory of normal distributions. Next we extend
the above theory to cases with unequal priors.
2.4.2. The case of unbalanced data
In the case of unbalanced data we let p denote the fraction of data with label +1 and
hypothesize the distribution of yi to be distributed as:
Pr(yi = +1) = p Pr(yi = −1) = 1− p (2.21)
This leads to an expected value and variance of yi:
E(yi) = 2p− 1 V ar(yi) = 4p− 4p2 (2.22)
We can use this to compute the expectation and variance of the components of w using
(2.11) as:
E(wj) = (2p− 1)
m∑
i=1
Cij V ar(wj) = (4p− 4p2)
m∑
i=1
C2ij (2.23)
Note that we may write equation (2.11) as:
wj =
m∑
i=1
Cijyi =
m∑
i=1
zji (2.24)
where we have defined a new random variable zji = Cijyi which is linearly dependent on yi.
Since the yi are subject specific labels we expect them to be independent of each other and
we can use the Lyapunov central limit theorem again to claim the asymptotic normality on
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the distributions of wj . However, application of this theorem requires:
lim
m→∞,d>>m
1[√∑m
i=1 V ar(z
j
i )
]2+δ m∑
k=1
E
[
|zjk − µ
j
k|
2+δ
]
for some δ > 0 (2.25)
where µjk = (2p− 1)Ckj To apply the Lyapunov CLT, we need the limit to vanish for some
δ > 0: We write down the limit for δ = 2 here, as opposed to δ = 1 in the last section. We
do this because the limits are easier to write down and intuit with δ = 2.
lim
m→∞,d>>m
∑m
k=1 p|Ckj − (2p− 1)Ckj |4 + (1− p)|Ckj + (2p− 1)Ckj |4[√
(4p− 4p2)
∑m
i=1C
2
ij
]4 (2.26)
The expectation is that this limit vanishes because the denominator contains cross terms
not included in the numerator implying Gaussianity.
To see this first note that:
lim
m→∞,d>>m
∑m
k=1 p(2− 2p)4|Ckj |4 + (1− p)(2p)4|Ckj |4[√
(4p− 4p2)
∑m
i=1C
2
ij
]4 (2.27)
may be broken down to
lim
m→∞,d>>m
∑m
k=1 p(2− 2p)4|Ckj |4[√
(4p− 4p2)
∑m
i=1C
2
ij
]4 + limm→∞,d>>m
∑m
k=1 (1− p)(2p)4|Ckj |4[√
(4p− 4p2)
∑m
i=1C
2
ij
]4 (2.28)
Since p, 1−p and 4p−4p2 are constants with respect to m, and the index i is interchangeable
with k this boils down to the limit:
lim
m→∞,d>>m
∑m
k=1 |Ckj |4
(
∑m
k=1C
2
kj)
4/2
= lim
m→∞,d>>m
∑m
k=1 (C
2
kj)
2(∑m
k=1C
2
kj
)2 = 0∗ (2.29)
For all experiments we performed using several different datasets this limit goes to zero. The
32
intuitive explanation for this is that The binomial expansion of the denominator contains
cross terms in addition to the terms in the numerator (a total of m2 terms), whereas the
numerator contains only m terms. This intuition obviously relies on the assumption that the
coefficients C2kj are of comparable magnitude for different values of k and grow consistently
with each other as m grows.
The question of what exact mathematical conditions are required for the limit in in (2.29)
to go to zero belongs to the realm of real analysis. But one may gain some insight into the
nature of this limit by further investigation of the matrix C. Recall that we already know
that:
C = XT[(XXT)−1 + (XXT)−1J(−JT(XXT)−1J)−1JT(XXT)−1] (2.30)
Note that the Cayley Hamilton theorem gives us for (XXT)−1
(XXT)−1 =
1
det(XXT)
m−1∑
s=0
cs(XX
T)s (2.31)
where cs are the appropriate constants.
Since the terms of XXT are ultimately quadratic in the Xuv (the elements of the data
matrix), the Cayley Hamilton theorem tells us that each term in the inverse can be expressed
as a ratio of polynomials whose degree depends on m. This combined with the fact that
−JT(XXT)−1J is essentially the sum of all terms in (XXT)−1 allows us to express the
elements of C as:
Ckj =
Pkj(Xuv)
Q(Xuv)
(2.32)
Here Pkj 6= 0 as long as the all entries in the jth column of X are not identical (that is we
do not deal with the degenerate case where wj will be 0). The limit, then boils down to:
lim
m→∞
∑m
k=1 (P
2
kj(Xuv,m))
2(∑m
k=1 P
2
kj(Xuv,m)
)2 (2.33)
Thus, given a specific value of m, the application of Cayley Hamilton theorem yields a
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common denominator polynomial Q for all elements of C. For a given m, the degrees of
the polynomials Pkj , are also identical for all values of k and j. This can be verified with
the use of the matlab symbolic math toolbox or Mathematica.
Since, the Pkj are polynomial functions of the elements of X of an identical degree, we expect
them to grow identically with m. That is, Pkj ∈ Θ(g(m,Xuv)). As long as a newly picked
sample does not look too different from historical samples (that is assuming exchangeability
in Xuv) we may safely assume Pkj ∈ Θ(g(m))
Then, setting ak = Pkj > 0 with q = 2, under the assumption that ak ∈ Θ(g(m)) for some
function g(m), we can show that:
lim
m→∞
∑m
k=1 a
q
k
(
∑m
k=1 ak)
q
= 0 (2.34)
To see this, note that the big-Θ notation implies that there exist constants M1 and M2 such
that M1g(m) ≤ ak ≤M2g(m).
Then for q > 1:
lim
m→∞
∑m
k=1 a
q
k
(
∑m
k=1 ak)
q
≤ lim
m→∞
mM q2 [g(m)]
q
mqM q1 [g(m)]
q
= lim
m→∞
1
mq−1
M q2
M q1
= 0 (2.35)
Also:
lim
m→∞
∑m
k=1 a
q
k
(
∑m
k=1 ak)
q
≥ lim
m→∞
mM q1 [g(m)]
q
mqM q2 [g(m)]
q
= lim
m→∞
1
mq−1
M q1
M q2
= 0 (2.36)
Then by the squeeze theorem on limits:
lim
m→∞
∑m
k=1 a
q
k
(
∑m
k=1 ak)
q
= 0 (2.37)
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In summary, if one makes an assumption of exchangeability of the Ckj with respect to the
sampling of X, then C2kj ∈ Θ(g(m)) and we have
lim
m→∞,d>>m
∑m
k=1 (C
2
kj)
2(∑m
k=1C
2
kj
)2 = 0 (2.38)
As such this assumption allows for a broad range of values of Ckj and seems to be met
in our experiments. A more formal treatment surrounding the behavior of this ratio is a
topic of research in mathematical statistics, is beyond the scope of this work. We refer the
interested reader to references (Fuchs et al., 2002; Ladoucette and Teugels, 2007; McLeish
and O’Brien, 1982) where the behavior above ratio has been treated with far more rigor.
2.4.3. The case of the soft margin SVM
The above permutation testing approximation procedure has been developed for hard mar-
gin SVMs. Suppose we were to use soft margin classification instead, how would it change
the approximation? First recall that typically for large values of the parameter ‘C’ in (2.2),
the SVM penalizes errors in classification heavily. Hence, the slack ξi = 0 ∀i. When
this happens the solution to the soft margin and hard margin cases are the same. When
perfect separability exists (such as the case of high dimensional low sample size data) the
advantage of setting ξi 6= 0 can be realized only at extremely small values of ‘C’ where the
optimizer typically forces ||w||2 , the first term in (2.2) to go to zero. When this happens
the approximation described above will break down. However, it is important to note that
typically the generalization performance of the classifier is also poor in when ‘C’ is very
small (see figure 4). This has been previously noted for neuroimaging data in (Rasmussen
et al., 2011). We found this to be true in our experiments as well (see figure 4).
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Figure 4: Top left: The effect of 10−10 < C < 1010 on the 5-fold cross validation accuracy(
red) and the objective of classification ||w||2 (green) for classification based on ADNI data.
Top right: Effect for fMRI based lie detection Bottom: Effect for simulated data
Figure 5: Comparison of weight vector component distributions and predicted normal dis-
tributions using permutation tests performed on real imaging data.
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2.5. Generating p-value maps to interpret SVM models
using the analytic framework
Let us denote the SVM model generated using the unpermuted labels by w∗. We can com-
pare w∗ with null distributions obtained using analytical (or actual) permutation tests to
get one p-value per voxel. These p-values can be collected into a p-value image. The mech-
anism of permutation testing implies that voxel locations where the p-values are small are
also voxel locations where components of w∗ differ significantly from the mean of the corre-
sponding null distribution This implies that the model w∗ significantly differs from a ‘null
model’ at these locations. Thus, we expect these locations to be important in distinguishing
controls from subjects. Our simulated experiments were in line with these expectations. Re-
gions where differences between patients and controls were simulated turned up with lower
p-values than the rest of the image. Thus, p-values generated by our analytic framework
may be used for morphometry in addition to interpret SVM models.
2.6. Experiments and results
In this section we present three sets of experiments. The first set of experiments validates
our statistical analysis framework with respect to simulated data. It also validates the
analysis framework proposed above. The second experiment uses quasi-simulated imaging
data. The third set of experiments demonstrates the application of this analysis framework
in real imaging data.
37
2.6.1. Experiments on simulated data
Experiment comparing the proposed analytic framework with univariate analysis
An important feature of the proposed analysis is that it can detect multivariate patterns
that univariate analysis will miss. This is despite the fact that we are performing hypothesis
testing on individual hyperplane coefficients. We demonstrate this behavior with a simple
experiment on simulated data. To simulate a multivariate effect we constructed labels
and data that could only be separated using two variables combined. Thus, we simulated
a bivariate pattern. Figure 6 (left) shows the simulated bivariate effect. These bivariate
variables are represented by the red and green columns of the data, that are repeated column
wise over and over again to simulate a differential effect between positively and negatively
labeled samples. To generate these bivariate data we 1) sample 100 points (zi) from a
standard uniform distribution 2) sample points ui from the standard normal distribution.
3) choose a factor f < 0.1 and generate point pairs (zi, zi + fui). 4) generate labels using
the criterion label = sign(fui). A plot of a specific set of these pairs is shown in figure 6.
Using this process we generated a hundred relevant features. Further, we added 400 noise
variables that had no relation with the labels to obtain the final dataset. Figure 6 (right)
illustrates the scheme of simulation. Figure 7 (top-left) shows p-values obtained by running
feature by feature univariate t-tests. Figure 7 (top-right) shows p-values obtained using our
analysis framework. Figure 7 (bottom) shows SVM weights obtained by running a linear
SVM using the data and the original labels. The figures show that the p-values generated
by univariate tests are in the range of 0.25 to 0.65 for all simulated bivariate features. The
p-values assigned by univariate testing to the remaining noise features also lie in the same
range. As opposed to this, p-values generated by permutation testing are in the range
0 to 0.05 for relevant features. This range is much lower than the p-values the method
assigns to the irrelevant features. The weight values associated by the linear SVM with
the relevant features are not necessarily higher (or lower) than the weight values associated
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Figure 6: (Left) Bivariate pattern simulated using two features, (right) illustration of sim-
ulation procedure
Figure 7: (Top-left) p-values from univariate testing on bivariate data (Top-right) p-values
from proposed analytic permutation tests on bivariate data (Bottom) Weight values learnt
by the SVM
with irrelevant features. Thus, the proposed permutation testing can detect multivariate
patterns that univariate testing (or SVM weight vector thresholding) might completely miss.
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Figure 8: (Left) p-values generated using univariate tests which detect the effect, (right)
p-values generated using SVM based permutation tests.
Experiment demonstrating the effectiveness of SVM based p-value maps in the
presence of purely univariate effects
For this experiment, we constructed a simulated dataset as follows. We constructed labels
and data that could be separated using only one variable. We repeated the univariate effect
variables over and over to obtain sufficient dimensionality. This constitutes a multivariate
pattern identifiable using univariate analysis. This pattern of relevant features spanned over
150 features. As before we added a large number of irrelevant noise variables that had no
relationship with the labels. The simulated dataset contained a total of 100 feature vectors
(50 labeled + 1 and 50 labeled 1) of dimensionality 2000. We introduced the simulated
univariate effect in 151 features. We performed univariate t-tests feature by feature to
obtain one p-value per feature. We then plotted these p-values in Figure 8 (left). We also
performed SVM permutation tests using the procedure described in the paper and plotted
the resulting p-values in Figure 8 (right). Figure 8 shows that univariate, as well as the
proposed multivariate analyses, recover the features of interest.
2.6.2. Experiments on simulated imaging data
Simulated imaging data were generated by modifying a subset of grey matter RAVENS
maps generated from raw T1-data of control images taken from the ADNI dataset. Specif-
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Figure 9: Results of experiments with simulated data. (a) A sagittal section through p-maps
obtained from experimental and analytical permutation tests. (b) A scatter plot of p-values
from experimental and analytical p-value maps. (c) Regions where simulated atrophy was
introduced.
ically, we used 152 GM-RAVENS maps. We divided these RAVENS maps into two equal
groups. In one of the two groups, (simulated patients) we reduced the intensity values of
GM-TDMs over two large regions of the brain. We did this to simulate the effect of gray
matter atrophy. We constructed these artificial regions of atrophy using 3D Gaussians.
The maximal atrophy introduced at the center of each Gaussian was 33%. The reduction
in the regions surrounding the center of this Gaussian was much lesser than 33%. We
show the regions where we introduced artificial atrophy in Figure 9. We trained an SVM
model to separate simulated patients from controls. We also performed permutation tests
to obtain empirical approximations to null distributions of the weight vector components.
We compared the components of the trained SVM models to the associated empirical null
distributions for obtaining ‘empirical p-maps. A similar comparison of SVM model com-
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ponents with theoretically predicted null distributions yielded analytic p-maps. Figure 9
presents a 2D section of these p-maps as well as a scatter plot (using the full 3D image) of
p-values obtained experimentally vs those obtained analytically. Figure 10 presents a visual
comparison of the p-value maps in 3D by thresholding p-maps at several arbitrarily chosen
thresholds. Figure 10 shows that analytically obtained p-maps are visually indistinguishable
from experimentally obtained ones and thus validates our analytic framework.
2.6.3. Experiments with Alzheimer’s disease data
In this section we discuss the application of our approach to interpreting SVM models
trained in real data. A total of 278 GM, WM and ventricular tissue density maps were
available for our experiment. The processed dataset contained images corresponding to 152
controls and 126 Alzheimer’s patients. All three tissue density maps of a particular subject
were downsampled and concatenated into a long vector and used as a feature vector for
the analysis. Actual permutation tests were then performed to experimentally generate the
null distributions and analytic approximations were also computed. We also trained an
SVM model using the original labels and compared its components to the pre-computed
experimental and analytic null distributions to obtain analytic and experimental p-value
maps. Figure 11 presents these p-value maps as well as a scatter plot of p-values obtained
experimentally vs those obtained analytically. Figure 12 presents a visual comparison of
the p-maps in 3D by thresholding p-maps at several at thresholds of 0.01 and 0.05. Figure
12 shows that the SVM model finds information from the hippocampal regions to be most
relevant to classification. Majority of literature implicates this region in the pathogenesis
of Alzheimer’s disease as well. Since the SVM model is based on this region we expect it
to have a high generalization accuracy. Indeed, this turns out to be true. Generalization
accuracy measured using the leave one out cross validation (LOOCV) accuracy for a linear
SVM classifier trained on this dataset is 86%.
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Figure 10: Simulated data: Experimental and analytical p-value maps thresholded at arbi-
trary p-values (3D).
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Figure 11: (Top left) Analytic and experimental p-value maps thresholded at 0.01 overlaid
on the template brain (Top right) A scatter plot of p-values comparing experimental and
analytical p-values.(Bottom) A 3D rendering representing predicted and experimental p-
value maps (Right) A scatter plot of p-values
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Figure 12: Experimental and analytical p-value maps thresholded at α = 0.01 and α = 0.05
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Figure 13: (Left) Experimental and analytical p-value maps thresholded at α = 0.05 overlaid
on a template brain (Right) scatterplot comparing analytically obtained and experimentally
generated p-values
2.6.4. Experiments with functional data
Functional data were preprocessed to obtain parameter estimate images (PEIs) as described
in (Davatzikos et al., 2005). A total of 44 PEIs, half of which consisted of lying responses
and half of which consisted of truth-telling responses were used for the analysis. These
data were obtained directly from the authors of (Davatzikos et al., 2005). Null distributions
were obtained using analytic and experimental permutation testing as before. An SVM was
trained using the actual labels as well. A section through the analytic and experimental
p-value maps thresholded at 0.05 is presented in figure 13. The scatter plot of analytic vs
experimental p-values generated using the entire 3D volume is also shown in figure 13. This
plot shows that the approximation is less accurate here as compared to the simulated data
or the Alzheimer’s disease data. This is possibly due to the relatively smaller sample size.
However, despite the relatively small sample size of 44 in this experiment it is still visually
difficult to tell the difference between the regions obtained by thresholding theoretically
predicted and experimentally obtained p-maps.
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2.6.5. Experiments to study the accuracy of approximation with
changes in sample size and dimensionality
An important question that is left unanswered by the qualitative analysis presented so far
is that of how the performance of the approximation deteriorates. Specifically the effect of
sample size and dimensionality on the approximation is not outlined by the experiments
described above. Another interesting aspect is the study of how the number of permutations
done in the experimental permutation tests affects the convergence of the approximation.
In this section we present experiments to gain some insight into these questions. These
experiments required the performance of empirical permutation tests with images of dif-
ferent dimensionalities and datasets of different sizes all of which had to be generated,
stored and loaded from memory on a large parallel cluster. As such an enormous amount
of computational time has gone into producing Figures 14, 15 and 16.
For all experiments presented here we have computed p-maps using the analytic approxima-
tion as well as empirical permutation testing. We use the average per voxel error between
the two p-maps as a measure of deviation of the approximate from the empirical permu-
tation testing result. Note that such a normalized measure of difference between images
is especially useful while studying the effect of dimensionality on the convergence of the
approximation. All three datasets described in the previous section have been used for ex-
periments performed in this section. In case of the Alzheimer’s disease dataset we randomly
chose 100 patients and 100 subjects instead of using the entire data. This was done because
it made it simpler to set up the experiment studying the effect of sample size. We describe
each set of the experiments in more detail next.
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Effect of number of permutations
We ran empirical permutation tests with 1500 permutations using all three datasets. We
stored the models corresponding to each permutation to disk. To obtain the approximation
accuracy for (randomly picked) one thousand permutations all we had to do was load 1000
results of the stored models, compute the empirical p-map and compare it with its analytic
counterpart. We used this approach to generate figure 14. Figure 14 shows the average per
voxel error in p-values obtained using actual permutation tests and the analytical approx-
imation for all three datasets. Figure 14 indicates that the error reduces exponentially as
the number of permutations increase.
Effect of reducing dimensionality
In this section, we address the impact of data dimensionality on the accuracy of the proposed
approximation. To generate data of varying dimensionality we subsampled the imaging data
at several different subsampling rates. Each subsampling rate yielded a new dataset whose
dimensionality was much smaller than the original data. Then we ran empirical permutation
tests (1000 random permutations) with SVMs on this subsampled data. We also computed
the analytical approximation for each of the subsampled datasets. We plot the per voxel
error rate between the analytic approximation and the experimental permutation testing
in Figure 15. It can be seen that reduced dimensionality leads to a higher error rate. This
indicates that the approximation works better when the data dimensionality is higher. We
expected this intuitively, given that the approximation of an SVM by an LS-SVM is better
when the dimensionality is higher. The experimental result simply confirms this intuition.
From figure 15 one may speculate that increased dimensionality leads to an exponential
decay in the approximation error.
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Figure 14: Approximation accuracy and number of permutations
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Figure 15: Effect of data dimensionality on approximation accuracy
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LASSO SVM permutations Truth
Lambda Number of
true posi-
tives
Number of
false posi-
tives
True pos-
itives at
p ≤ 0.05
False pos-
itives at
p ≤ 0.05
1 0 0 151 0 151
0.9 2 0 151 0 151
0.5 17 0 151 0 151
0.05 69 0 151 0 151
0.004 99 0 151 0 151
0.002 95 9 151 0 151
Table 1: Comparison between LASSO and SVM permutation test based approach
Effect of reducing sample size
We have based the proposed analytic approximation on the central limit theorem. Hence
we expect that an increased sample size would improve approximation accuracy. To under-
stand the effect of sample size we consecutively halve the sample size and re-run both the
empirical permutation tests (1000 random permutations) and the analytic approximations.
For instance, if we had 100 patients and 100 controls, we ran experiments with the whole
dataset, a dataset with 50 patients and 50 controls and 25 patients and 25 controls. In
case of the Alzheimer’s and fMRI datasets we added an extra point (75% of the full sample
size) to better map the effect of sample size in this range. Figure 16 shows the variation
of approximation accuracy with sample size for all three datasets that we ran experiments
on. As expected, a larger sample size leads to higher accuracy. Note that even for sample
sizes close to 20 the error in p-values is small (order of 105) for the fMRI data. In the
Alzheimer’s disease data where the dimensionality was substantially higher, the error is
always in the order of 106. Just like dimensionality, increased sample size also seems to
produce an exponential reduction in the error of approximation.
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Figure 16: Effect of data dimensionality on approximation accuracy
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Elastic net SVM
permu-
tations
Truth
Lambda Alpha Number
of true
positives
Number
of false
positives
True
posi-
tives at
p ≤ 0.05
False
posi-
tives at
p ≤ 0.05
1 0.25 138 0 151 0 151
1 0.75 15 0 151 0 151
0.1 0.25 138 0 151 0 151
0.1 0.75 82 0 151 0 151
0.01 0.25 106 7 151 0 151
0.01 0.75 90 0 151 0 151
0.001 0.25 72 81 151 0 151
0.001 0.75 93 53 151 0 151
1 0.05 151 0 151 0 151
Table 2: Comparison between elastic nets and SVM based permutation tests
2.6.6. Experiments comparing the proposed approach to sparse
methods
A substantial body of literature has been developing around so called sparse methods for
multivariate image analysis. For instance, methods described in (Ryali et al., 2012; Sabuncu
and Van Leemput, 2011; Batmanghelich et al., 2012) attempt to apply sparsity to make
interpretations/inferences. This is a growing body of literature and comparing the proposed
method with every possible method out there is beyond the scope of this thesis. A large
fraction of sparse methods use L-1 norm minimization. Hence we compared the proposed
method with two methods that we believe to be representative of this literature. We com-
pared SVM based permutation tests with the LASSO and the elastic net. We used the
dataset used for generating figure 8. We ran LASSO for variable selection repeatedly with
decreasing parameter values until the procedure started picking up false positives (started
behaving like ordinary unregularized regression). We also ran elastic nets with several pa-
rameter settings, recorded the results and compared with the SVM permutations based
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method. We tabulated results for the LASSO in table 1 and the results for the elastic net
in table 2. From the tables, we can see that the LASSO can never find more features than
the number of samples. This is a known limitation of the LASSO and one of the primary
reasons for using Elastic nets. Selection of the minimum number of features using cross
validation will yield an answer of 1. This alone is reason enough to avoid using the LASSO
in neuroimaging analysis. In general we wish to use and visualize all regions used for pre-
diction (and not eliminate them from the analysis). The SVM based permutation approach
does not suffer from this limitation of the LASSO. The elastic net remedies the limitation of
the LASSO and can find all the features introduced for certain parameter values. However,
it still suffers from the parameter selection problem. In the simulated case, where relevant
features are highly correlated cross validation based parameter selection would give the
same accuracies whether we select one relevant feature or 151 relevant features. In such a
case cross validation based parameter selection fails for the elastic net as well. Again SVM
based permutation tests do not suffer from these limitations on account of their simplicity.
While doing so they still retain the capability to find multivariate patterns and allow for a
rigorous statistical p-value based interpretation.
2.6.7. When not to use the analytical approximation to permuta-
tion testing
One of the base assumptions in our approximation is that support vector machines treat all
data as support vectors when attempting to learn from high dimension low sample size data.
On the other hand the central limit theorem is an asymptotic result. This naturally leads to
the question how much bigger than m does d have to be to safely apply the approximation.
In order to understand this further we present here a plot of the ratio m/d to the ratio of
nSV s/m for simulated univariate data from the paper for various values of dimensionality
d. It can be seen from the plot that for m/d > 0.2, less than 95% of samples remain
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Figure 17: Plot of adherence to assumption that all samples are support vectors as m gets
closer to d. Recall that m is the number of samples and d is the dimensionality of the data.
support vectors during permutation tests. This would constitute a substantial deviation
from our assumption. Thus, it may not be wise to use the approximation in such a case.
Fortunately, for image analysis, the number of voxels in an image (even a downsampled
image) is in the range of millions while sample sizes barely touch a few hundreds. Thus, we
expect m/d << 0.2 for neuroimaging studies for the most part. However, one must refrain
from applying this approximation in case m/d gets too large.
2.7. Extending the proposed framework to Interpreting
support vector machines (SVM) regression models
The theoretical and experimental developments presented so far concern support vector
classification. Support vector regression analysis, on the other hand involves predicting a
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continuous variable using imaging data. This variable can be a clinical score, age or even
a protein or gene expression level. The support vector regression (SVR) algorithm may be
used for addressing regression analysis in neuroimaging.
The SVR algorithm can predict continuous clinical variables from images. However, it pro-
vides no direct mechanism to assess what image regions were most significant in arriving
at the predictions. This question is relevant in large clinical studies and is often asked by
clinicians who lead such studies. Traditionally, regions associated with continuous clinical
variables are found using mass univariate voxel based analysis (VBA). Such analysis as-
sociates a statistical significance test with each voxel in the image by regressing the voxel
intensity directly with the target variable. Unlike MVPA, univariate analysis cannot predict
target clinical variables and misses multivariate patterns in data. A multivariate alternative
to VBA that is based on the interpreting a model learnt by an MVPA method such as an
SVR is thus required and presented here.
Thus, in this section we describe a p-value based permutation testing based solution on the
lines of what was presented in the previous section. We also extend the analytic approxi-
mation to cover the case of support vector regression. Analogous to classification we expect
the proposed approach to highlight image regions used by the SVR to make predictions
about the continuous output variable. We present the theory behind our approach along
with the necessary background information on support vector regression next.
2.7.1. Support vector machines for regression
Regression analysis involves prediction of continuous clinical variables using medical images.
The task at hand may be to predict clinical scores associated with disease stage or disease
progression in patients. Regression models trained on normal data may be used to quantify
mental age or infer gene/protein expression levels in at risk individuals. As in classification
multivariate pattern analysis(MVPA) techniques such as support vector regression (SVR)
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Figure 18: (Left) Support vector regression as applied in medical imaging. (Right)Concept
of support vector regression in high dimensional space
directly address the image based regression paradigm. Most MVPA algorithms including
SVR learn a model of disease by training on image data with known target variables. Target
variable associated with a hitherto unseen test image can be computed using the ‘learnt
model’ (see figure 18).
For training an SVR we stack preprocessed training image data into a large rectangular
matrix X ∈ Rm×d whose rows xi index individuals in the population, and columns index
image voxels. A continuous target variable yi ∈ R is associated with every individual xi for
the training dataset. Further Note that the vectorized images xi live in a Euclidean space
57
of dimension d. Then the ε−SVR solves the following optimization problem:
w∗, b∗ = minw,b,ξi,ξ∗i
1
2
||w||2 + C
m∑
i=1
(ξi + ξ
∗
i )
subj.to. wTxi + b− yi ≤ ε+ ξi
yi −wTxi − b ≤ ε+ ξ∗i
ξi, ξ
∗
i ≥ 0 ∀i ∈ {1, ...,m} (2.39)
The solution fits a tube of width ε -tube to the data (Schölkopf and Smola, 2002). When
the number of samples is higher than the number of samples (m > d) then finding a tube
of width ε that always contains all the data is not always feasible. The slack parameters ξi
and ξ∗i then allow a few datapoints to lie outside the ε -tube. In the medical image analysis
setting we have p > n, that is the dimensionality is always much greater than the sample
size. In this setting it is always possible to fit a d-hyperplane or a d-dimensional ε-tube
through all the data points. Hence practically for all values of C, the solution to (2.39) is
the same as the solution to:
w∗, b∗ = minw,b
1
2
||w||2
subj.to. wTxi + b− yi ≤ ε
yi −wTxi − b ≤ ε
∀i ∈ {1, ...,m} (2.40)
Since the medical image analysis setting is almost exclusively high dimension low sample
size we focus on the solutions to (2.40) instead of solutions to (2.39) throughout the rest of
this article.
The SVR model is represented by the pair {w∗, b∗}. For a new test subject whose vectorized
image is represented by xtest the prediction ytest made by the SVR algorithm is ytest =
w∗Txtest + b
∗.
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2.7.2. Permutation testing for support vector regression
Figure 19: Concept of permutation testing in support vector regression. Comparison of w∗
to the null distribution generated by {w(1)null, ....,w(k)null} is used for inference
Note that the dimensionality of the model vector ‘learnt’ by the SVR w∗ is the number
of voxels in the image, that is w∗ ∈ Rd. Thus every component of the vector w∗ can
be mapped to a specific voxel in the image domain. This mapping associates an image
with the SVR model. Henceforth, we call this image a w-map. It is tempting to use to
directly use this image for making inferences about which regions are most significantly
involved in making predictions. However, these weights 1)can be biased to be large by the
a simple scaling/translation operations on the underlying voxel intensities 2) provide no
measure of statistical significance of a specific feature/voxel in the image. Thus a more
appropriate method for interpreting the SVR model is needed. Permutation testing is
one such method. The concept of permutation testing for SVRs in 2 dimensional space
is illustrated by figure 19. In permutation testing, the target variables yi are permuted
randomly. For each random permutation an SVR is used to compute w∗randperm. After
many thousands of permutations we can generate an approximation to the null distribution
of every component of wj → N jnull where j ∈ {1, ...., d}. Finally, the original labels are used
to train w∗. Comparing the components w∗j with N
j
null gives us a p-value associated with
59
every voxel. It is important to note that the null distribution at any voxel depends on the
null distribution at all other voxels. This dependence is also true for the components of w
themselves. Hence, each component wise test is based on data from all image voxels and is
not univariate in the VBA sense.
2.7.3. The analytical approximation of permutation testing
In this section we present an analytical approximation to SVR based permutation testing.
This approximation connects SVR permutation testing to standard statistical theory based
on the normal distribution. Further it makes it possible to run multivariate analysis using
computational resources comparable to what is required for VBA analysis. The fundamental
assumption behind the analytical approximation is that in high dimension low sample size
data for most random permutations majority of the samples lie on the support vector
hyperplanes. This is analogous to the assumption made with respect to support vector
classification. This assumption does not typically hold for the model trained with the
actual targets since usually there is enough structure in the data to learn from. However,
since most permutations are random the only way the algorithm can fit a model compatible
with the entire dataset is by storing all of the data points and their labels as support vectors.
Under this assumption, for most permutations the solution to (2.40) can be approximated
by the solution to:
w∗, b∗ = minw,b
1
2
||w||2
subj.to. wTxi + b− yi = ε
OR
yi −wTxi − b = ε
∀i ∈ {1, ...,m} (2.41)
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Now note that one of the two constraints has to hold for every sample for every permutation.
For a particular permutation a specific sample can either adhere to one constrain or another.
Thus, for a particular permutation the optimization given by (2.41) can be solved using
Lagrange multiplier theory as before to yield:
wj =
∑
i
Cij(yi + Jiε) (2.42)
where Ji = ±1 depending on the constrain which holds for the corresponding sample and
Cij are elements the matrix C ∈ Rd×m given by:
C
.
= XT[(XXT)−1 + (XXT)−1J(−JT(XXT)−1J)−1JT(XXT)−1] (2.43)
Now over a large number of permutations we can expect either constraint in (2.41) to hold
with a probability of 1/2 for each sample. Thus we may write the generic solution to (2.41)
as:
w = C(y + L) (2.44)
where the vector L ∈ Rm with components Li = ±ε and:
P (Li = +ε) = 1/2 P (Li = −ε) = 1/2 (2.45)
Note that (2.44) can also be written in its component form as:
wj =
m∑
i=1
Cij(yi + Li) (2.46)
Since the Cij are completely determined by the data matrix X we can treat these as con-
stants and take expectations on both sides of (2.46) to obtain:
E(wj)
m∑
i=1
CijE(yi + Li) = E(yi)
m∑
i=1
Cij (2.47)
Note that E(Li) = 0 and that E(yi) does not change with i allowing us to pull it outside
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the summation sign. To explicitly acknowledge this invariance, henceforth we denote E(yi)
simply as E(y). Similarly the variance of wj can be predicted by taking variances on both
sides:
V ar(wj) =
m∑
i=1
C2ij(V ar(yi) + V ar(Li)) = (V ar(yi) + ε
2)
m∑
i=1
C2ij (2.48)
Note again that the term V ar(yi) + ε
2 is invariant with respect to i. Henceforth we denote
this term as V ar(y) + ε2. Thus, we write:
E(wj) = E(y)
m∑
i=1
Cij V ar(wj) = (V ar(y) + ε
2)
m∑
i=1
C2ij (2.49)
In regards to the distribution of wj it can be shown to be normal using the Lyapunov central
limit theorem as before. To see this define zji = Cij(yi +Li) which is linearly dependent on
yi + Li. We can infer the expectation and variance of z
j
i from yj as:
E(zji ) = CijE(y) V ar(z
j
i ) = C
2
ij(V ar(y) + ε
2) (2.50)
Note that zji may be regarded as independent but not identically distributed and wj are
linear combinations of zij . Thus, according to the Lyapunov central limit theorem(CLT) wj
is distributed normally if:
lim
m→∞
1[√∑m
i=1 V ar(z
j
i )
]2+δ m∑
k=1
E
[
|zjk − µk|
2+δ
]
= 0 for some δ > 0 (2.51)
For δ = 1.
E
[
|zjk − µk|
2+δ
]
= E
[
|Ckjyk − CkjE(yk)|2+δ
]
= C3kjE
[
|yk − E(yk)|3
]
(2.52)
Again we note that E
[
|yk − E(yk)|3
]
is independent of k and henceforth denote it simply
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as E
[
|y − E(y)|3
]
. Then, we can write the limit in (2.51) as:
lim
m→∞
E
[
|y − E(y)|3
]∑m
k=1C
3
kj[√
(V ar(y) + ε2)
∑m
i=1C
2
ij
]3 = K

√√√√ lim
m→∞
∑m
k=1C
2
kj∑m
i=1C
2
ij
3 = 0 (2.53)
where K is a constant independent of the sample indices k and i, defined by:
K =
E
[
|y − E(y)|3
][√
(V ar(y) + ε2)
]3 (2.54)
Note that we have already investigated the limit in (2.53). It tends to zero under the
assumptions presented before. Thus, in the limit we have normality of wj by the Lyapunov
central limit theorem.
2.7.4. Experiments and results
In this experiment, we applied the proposed method to the problem of white matter matu-
ration in mouse brains. We used ex vivo acquired Diffusion Tensor images of a population
of 79 inbred mice of C57BL/6J strain. The imaged mouse correspond to different postnatal
stages, ranging from day 2 to day 80 (Verma et al., 2005). Early developmental stages were
sampled more densely because development is more emphasized during that period.
The images were deformably registered to a template image chosen from the age group of
day 10 using DROID (Ingalhalikar et al., 2010). DTI-Studio (Jiang et al., 2006) was used to
estimate tensors from which, the Fractional Anisotropy was calculated resulting in images
with dimension 300× 300× 200.
As in the previous sections, we compare the experimental p-map with the analytic one.
By visually comparing correspond slices from the two maps, we note that the predicted
values closely follow the actual ones Fig. 20. We also observe distinctively low p-values in
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Figure 20: Representative slices of analytic and experimental p-maps (left) and scatter plot
of corresponding analytic and experimental p-values for mouse brain data.
the cortex and the genu of corpus callossum. These areas have been previously reported
exhibiting noteworthy maturation profiles (Verma et al., 2005). The scatter plot suggests
that analytic and experimental p-values agree and highlight cortical connectivity changes
in the developing mouse brain.
2.8. Conclusion
In this chapter we have described an analytic framework to interpret support vector mod-
els using statistical p-values. Our framework attaches a p-value based interpretation to
diagnostic disease models learnt from imaging data using SVMs. We can use this machin-
ery to quantitatively understand which regions/features contribute statistically significantly
to the diagnosis made by a machine learning tool such as the SVM. Further, we can use
it to compare two models generated using different data or in different populations in a
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mathematically rigorous p-value based framework.
Our approximation to permutation testing makes multivariate analysis using SVMs possible
using memory/time comparable to univariate VBM analysis. Thus, it provides a multivari-
ate alternative to VBM type of univariate population based analyses. While we retain the
advantage of multivariate analyses, our method scales well with increasing dimensionality
and sample size. As imaging technology advances, we expect higher dimensionalities and
higher sample sizes. Thus, the ability to perform multivariate population analyses inspite
of ever increasing data sizes is of paramount significance. The methods we have presented
above address this challenge appropriately.
2.8.1. A note on software
Throughout this work we use SVM implementation provided by the authors of LIBSVM
(Chang and Lin, 2011). This is one of the most widely used and well tested libraries
implementing SVMs in current practice.
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CHAPTER 3
Improved interpretation of diagnostic
SVM models: Enhancing inference
using margin weighted statistics
3.1. Introduction
In this chapter we build upon the statistical analysis framework presented in the previous
chapter. Consequently, the work presented in this chapter draws upon the work presented
in the previous chapter quite heavily. In the previous chapter we developed a weight vector
based framework for interpreting SVM models that applies in the high dimension low sample
size settings found in neuroimaging. In this chapter we note that statistics based on w,
developed in the previous chapter, ignore a very important aspect of SVM theory, namely,
the margin. This is an issue of critical importance since the SVM margin is closely related
to the generalization error of the classifier and dictates the quality of the learnt model.
Classification with a wider margin is inherently better than classification with a narrower
one. This is in fact the basis of SVM theory (Vapnik and Vapnik, 1998). Using w alone,
risks accepting the null hypothesis even when the margin associated with SVM classification
is very high leading to very conservative inference. Thus, permutation testing must be done
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with a statistic that is margin aware.
We introduce such a ‘margin aware’ statistic in this chapter. As expected, this statistic
is closely tied with the w itself. On account of its relationship to w the null distribution
associated with the proposed statistic is also Gaussian and in the high dimension low sample
size case inference may be based on the normal distribution. Further, using simulated data
we show that inference based on the margin aware statistic is superior in several aspects to
analysis using the weights themselves. Wherever necessary, we repeat certain formulations
and statements from the previous chapter for the sake of completeness and ease of reading.
3.2. The key challenge: SVM theory motivating the
definition of margin based statistics
In this section we review SVM theory that drives the intuition behind the margin based
statistic. While this is not meant to be a comprehensive review of SVM theory, we do
present certain theoretical aspects that are relevant to the problem at hand.
First, the generalization performance of SVMs is usually measured in terms of the leave one
out cross validation error (LOO error). Leave one out cross-validation involves leaving one
sample in the training data set out and then training the algorithm on the rest of the data.
Testing is done on the left-out subject. This process is repeated by leaving each possible
sample out one at a time and estimating the average error over all the runs. Theoretical work
presented by (Vapnik and Chapelle, 2000; Vapnik and Vapnik, 1998) presents several bounds
on the expected leave one out error as a function of model and dataset characteristics. The
simplest of these bounds is the radius margin bound. Specifically, if R is the radius of a
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Figure 21: (a) Classification hyperplane with small margin (b) Classification hyperplane
with larger margin preferred by SVM optimization. Also shown is the vector ρw||w|| which
encodes margin information and is proportional the statistic used in this paper.
hypersphere containing all the data in high dimensional space, then:
E(LOOCV error) ≤ 1
m
E(4R2||w||2) (3.1)
Since the SVM margin is inversely proportional to ||w||, this is often known as the radius
margin bound. Noting that the margin as measured between alternately labelled support
vectors may be written as:
ρ =
2
||w||
(3.2)
the bound becomes:
E(LOOCV error) ≤ 1
m
E(
R2
ρ2
) (3.3)
Thus, we expect models associated with higher margins to yield a lower generalization error
in classification. For the purposes of inference using permutation testing this implies that we
must give more consideration to weights of SVM models with larger margins as compared
to weights of SVM models with smaller ones. This is precisely the intuition behind the
margin based statistic.
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3.3. Addressing the key challenge: The margin based
statistic
Based on the intuition presented above we now define the margin based statistic. For each
component wj of w we define:
sj =
ρ
2
wj
||w||
(3.4)
The statistic sj represents the components of the vector
ρw
||w||2 that is perpendicular to the
separating hyperplane and has magnitude proportional to the margin associated with the
classifier. This geometric interpretation is shown in two dimensions in figure 21. From
figure 21 one can see that this new statistic incorporates not only the direction of SVM
hyperplane but also the margin that it achieves. Using sj instead of wj for permutation
testing incorporates the higher confidence associated with a higher margin directly into the
statistical p-values generated by the permutation procedure. This is the primary theme
of this chapter. We show using experiments that using sj ultimately yields better inter-
pretation as well. In the next section we extend the analytical framework of chapter 2 to
permutation testing using sj .
3.4. Analytic approximation for margin based permuta-
tion testing
In this section we show that inference using the statistic sj can be done by comparing the
value of this statistic at each voxel to a specific normal distribution. This is motivated
by the fact that permutation testing with sj yields a null distribution that is Gaussian in
nature. We briefly review the relevant aspects and equations on the previous chapter and
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proceed to develop the approximation based on these.
As in chapter 2 we consider imaging data are vectorized and xi ∈ Rd represents the ith
image. Pathological (or functional) states are denoted by labels yi ∈ {+1,−1}. and the
SVM model is parameterized by w ∈ Rd, the solution to:
{w∗, b∗} = min
w,b
1
2
||w||2
subj.to. yi(w
Txi + b) ≥ 1 ∀i = 1, ...,m
(3.5)
where m is the number of subjects in the training data. p-value based inference associated
with this model may be achieved by comparing each component w∗j to the null distribution
given by:
wj − µj
σj
D−→ N (0, 1)
as m→∞ with
µj = (2p− 1)
m∑
i=1
Cij σ
2
j = (4p− 4p2)
m∑
i=1
C2ij (3.6)
with i ∈ {1, ....,m} indexing the samples, j ∈ {1, ..., d} indexing voxels and p being the
fraction of labels that are +1. Cij are elements of the matrix C defined as:
C = XT[(XXT)−1 + (XXT)−1J(−JT(XXT)−1J)−1JT(XXT)−1] (3.7)
with J ∈ Rm being a vector with each component equal to 1 and X ∈ Rm×d is a matrix
with d >> m formed by stacking vector representations of imaging data as explained in
the previous chapter. Our task in this section is then to derive a related distribution that
allows for p-value based inference using sj instead of wj . To see this we begin by by noting:
CJ = 0 (3.8)
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Thus:
m∑
i=1
Cij = 0 =⇒ µj = 0 =⇒ E(wj) = 0 (3.9)
We then proceed using Taylor asymptotic approximations to estimate the mean and the
variance of sj (Casella and Berger, 2002):
E(sj) = E
( wj
wTw
)
≈ E(wj)
E(wTw)
= 0 (3.10)
And similarly we can approximate the variance as:
var (sj) ≈
var(wj)
E(wTw)2
+
E(wj)
2
E(wTw)4
var(wTw)
− 2 E(wj)
E(wTw)3
cov(wj ,w
Tw)
=
var(wj)
E(wTw)2
(3.11)
We estimate E(wTw) using the theory of quadratic forms (Searle, 2012):
E(wTw) = tr(Σw) + µ
Tµ =
d∑
k=1
(σk
2 + µ2k) =
d∑
k=1
σk
2 (3.12)
Thus, we can write (3.11) as:
var
( wj
wTw
)
≈ var(wj)
E(wTw)2
=
σ2j[∑d
k=1 σ
2
k
]2 (3.13)
Further, since sj may be written as a continuous and smooth function of the components
of w which are themselves normally distributed with a positive definite covariance matrix,
we have that sj is approximately normally distributed by the multivariate delta method
(Casella and Berger, 2002):
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 σj[∑d
k=1 σ
2
k
]
−1 sj D−→ N (0, 1) (3.14)
An alternate explanation of normality may be uncovered by writing down the cumulant
generating function (CGF) for the distribution of sj . Recall that the CGF of a random
variable t may be written as:
g(t) = log(E(eqt)) = E(t)q + [E(t2)− E(t)2]q
2
2!
+[E(t3)− 3E(t2)E(t) + 2E(t)3]q
3
3!
+ ... (3.15)
For the statistic si we note that the order of magnitude of the cumulants is in increasing
powers of wi
wTw
:
E(sj) ∼ (wj/wTw)
E(s2j )− E(sj)2 ∼ (wj/wTw)2
E(s3j )− 3E(s2j )E(sj) + 2E(sj)3 ∼ (wj/wTw)3
(3.16)
Recall that we are working under the assumption that:w
(wj/w
Tw) >> (wj/w
Tw)2 >> (wj/w
Tw)3 >> ... (3.17)
Ignoring terms with a cubic or higher order in (3.15) the yields:
log(E(e
q(
wj
wTw )) ≈ E
( wj
wTw
)
q +
[
E
([ wj
wTw
]2)
−
[
E
( wj
wTw
)]2] q2
2!
(3.18)
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Now using (3.13) we can write:
log(E(e
q(
wj
wTw )) ≈ (0)q +
σ2j[∑d
j=1(σ
2
j + µj)
]2 q22! (3.19)
which is exactly the CGF of the Gaussian distribution with mean and variance given by
(3.10) and (3.13) respectively.
In the next section we present experiments and results that validate the proposed statistic
and the analytic inference framework associated with it.
3.5. Experiments and Results
3.5.1. Experiments on simulated data 1
In this section we present inference on simulated datasets using the proposed framework.
The primary aim of this section is to demonstrate the validity of the proposed machinery
and to show that permutation testing with sj is at least as effective as permutation testing
with wj presented in the last chapter. Towards this end we demonstrate how inference using
sj successfully identifies regions driving group differences in simulated datasets similar to
the ones used in the previous chapter. We show that the proposed statistic can indeed
identify features/regions we would expect the SVM model to utilize for making a diagnosis.
We simulate high dimension low sample size data that contain univariate and multivariate
effects of interest which differentiate two subsets of the data. When single features (voxels
in neuroimaging; genes and measures of their expression in genomics) can be used to detect
differences between two groups, we say that a univariate effect is present at that feature.
When one feature has to be used in conjunction with another (or many other) features to
distinguish between two groups we say that multivariate effects are present. We simulate
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Figure 22: Inference for data where univariate effects may be used to distinguish labels (left)
with p-values calculated by t-tests (middle) p-values calculated by permutation testing using
the margin aware statistic and (right) p-values calculated by the analytical approximation
to permutation testing using the margin aware statistic
data with both univariate and multivariate effects and show that our framework can be
used to identify these effects. We also contrast our method with the widely used univariate
analyses. Results presented in this section establish that inference using sj is at least
comparable to inference using wj presented in the previous chapter. The next section
demonstrates how it is actually better.
3.5.1.1. Detection of simulated univariate effect
The aim of simulation was to show that the proposed statistic can detect regions that differ
between groups in a univariate sense. The data simulation scheme is similar to the one
used in chapter 1 (in the section named ‘Experiment showing the value of permutation
testing analysis with respect to univariate analysis’). Briefly it involves 1) generation of
random noise data X ∈ R100×2000 by sampling a standard uniform distribution 2) random
assignment of labels +1 and −1 to the 100 samples 3) subtracting a fixed value of 0.3 from
350 features in all samples labeled +1. The results are presented in figure 22.
The intention here was to simulate an effect which could easily be detected using a t-test.
This can be seen from the low p-values assigned by the t-tests to the subtraction region in
figure 22. The SVM based permutation test using the margin aware statistic can find this
region as well. The analytic approximation to the margin based statistic is equally effective
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in identifying the required region. Thus, the performance of our proposed statistic and the
associated inference framework is at least comparable to the t-test when pure univariate
effects differentiate between high dimensional data.
3.5.1.2. Detection of simulated multivariate effect
While univariate analysis using t-tests can detect effects simulated above, they cannot detect
multivariate effects like the ones simulated in figure 6. The weight map based statistics wj
presented in the previous chapter are capable of detecting these effects. In this subsection
we show that this capacity is inherited by sj as well. Again we present a simulation on the
lines of that shown in figure 6. Bivariate features are generated as before and represented in
figure 23 where the green circles and blue crosses indicate distinct labels. The x and the y
co-ordinates of each point represent values of features. Note that either x or y , used alone
cannot differentiate blue from green. However, when used together one can easily draw a
line that separates blue from green on the plot. As in chapter 2 we generate these bivariate
features by 1) sampling 100 points (zi) from a standard uniform distribution 2) sampling
points ui from the standard normal distribution. 3) choosing a factor f < 0.1 and generate
point pairs (zi, zi + fui). 4) generating labels using the criterion label = sign(fui)
However, this time we increase the total number of signal features and noise features. We
use a total of 400 signal features (as opposed to 100 in the previous experiment) and 1600
noise features (as opposed to 400 in the previous experiment). The alignment of the signal
and noise features is also illustrated in figure 23.
For inference purposes we run t-tests, actual permutation tests using the margin aware
statistic and the analytic permutation tests proposed. The results are presented in figure
23. We also show SVM weights corresponding to the simulated features in figure 23 for
comparison purposes. The figure shows that SVM weights or t-tests alone may not be
sufficient to identify regions that the SVM model uses for classification. Using permutation
testing to model the variance of the weights provides a certain edge over using the weights
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Figure 23: (Top-left)Features which can be used in a combined way but cannot be used
individually to separate categories (Top-right) Illustration depicting simulation procedure
for generation of multivariate toy data (Bottom) Inference on multivariate toy data p-
values generated using standard t-tests (left) Inference using experimental permutation
tests (middle-left) Inference using analytic permutation tests (middle-right) Inference using
SVM weights (right)
directly or over univariate testing in this sense.
Both experiments presented above essentially focus on comparing permutation testing using
sj to permutation testing using wj . We show that these two are comparable in both the
univariate and the multivariate setting. Next, we present experiments contrasting the two.
We build a case for why sj should be used for permutation testing instead of wj
3.5.2. Experiments on simulated data 2
The main problem with permutation testing using wj is its sensitivity to abnormality size.
SVM weights associated with each voxel/feature get smaller if the number of voxels/features
driving the group difference increase. This raises the p-values associated with these features
and reduces the sensitivity of the associated p-value map. In this sense using ‘w’ alone
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seems to work more like the LASSO or the elastic net. We show here through simulated
experiments that the margin based statistic alleviates this shortcoming.
3.5.2.1. Effect of simulated abnormality size on the analysis
In order to demonstrate the increased sensitivity of the weight based statistic to the size
of the abnormality we create 3 separate datasets. Each of these datasets have their own
simulated abnormality. The procedure used to create the data includes 1)generation of a
random noise matrix of size R100×10002) 2) Randomly labeling 50 of these samples as +1
and the other 50 as −1. 3) Subtracting 0.3 from a pre-chosen subset of the 1000 features.
Depending of the effect desired we chose either 50, 150 or 250 features from which the
subtraction was made. For each of these datasets we show a plot of p-values generated using
a) univariate testing b) the analytic approximation to the SVM weight vectors presented
in chapter 1 c) The analytic testing framework proposed in this paper. These results are
shown in the figure 24. From figure 24 we see that 1) using permutation tests based on
SVM weights can detect small abnormalities 2) as the dimensionality increases, p-values
based SVM weights can get as high as 0.8-0.9 which makes the abnormality undetectable at
the standard threshold 0.05 3) The margin based p-value is relatively robust in this respect.
In the following subsection we present similar results in neuroimaging data with simulated
abnormalities.
3.5.2.2. Neuroimaging data with simulated abnormalities of different sizes
All the previously presented simulations use simulated effects as well as simulated noise.
In order to bring the simulations closer to actual neuroimaging data we present a few
experiments in this subsection using actual neuroimaging data. For this experiment we
used grey matter tissue density (RAVENS) maps generated using ADNI data that was used
in the prior experiments as well.
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Figure 24: (Left column) p-values generated using t-tests with red circles indicating the
location of the ground truth simulated effects (Middle column) p-values generated using
SVM weights alone as described in chapter 1. Note that as the size of the simulated
abnormality is increased the p-values increase to as high as p=0.8. Orange circles indicate
the approximate location of ground truth (Right column) p-values generated using the
margin based statistic. Green circles indicate approximate location of ground truth.
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Figure 25: Detecting focal and non-focal simulated effects in neuroimaging data. First two
columns from the left show detection using proposed statistic. Third column shows regions
detected using permutations based on SVM weights only. The last column shows ground
truth
We chose 152 grey matter RAVENS maps , from selected normal controls and introduced
simulated an abnormality in exactly 76 of them. The region in which the abnormality was to
be introduced was painted in using ITK-SNAP (Yushkevich et al., 2006). The abnormality
is simulated by reducing the map intensity by 30%.
We used both SVM weight based permutation tests of chapter 2 and the margin based
statistic described in this chapter to analyze the data. We also performed the above sim-
ulation with both, a small and a large simulated abnormality. The results are shown in
figure 25. In general the following conclusions may be drawn from figure 25: First even in
the presence of the noise profile associated with actual neuroimaging data, the proposed
method of inference performs well. Second, this experiment re-iterates the finding that
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inference based on permutation tests using SVM weights is highly sensitive to the size of
the simulated abnormality. The margin based statistic does not seem to suffer from this
problem.
3.5.3. Experiments with ADNI data: Qualitative analysis
The aim of the experiment presented here was to present a use case of our framework in real
data. We also show qualitative comparisons between p-values produced by the analytical
and experimental analysis frameworks. We use 100 controls and 100 patients from ADNI for
this experiment. Grey matter, white matter and ventricular RAVENS maps were computed
for each subject. All 3 RAVENS maps were downsampled and concatenated into a single
long vector. Thus, we obtained one feature vector per subject. One thousand SVMs were
trained using random permutations of the labellings (controls and patients) to obtain the
null distributions of the proposed statistics for these subject specific feature vectors. These
null distributions were used to compute experimental p-values. The analytical p-values were
obtained using the distributions described by the framework presented in this chapter.
Figure 26 shows volumetric renderings of the negative logarithm of p-values corresponding
to the grey matter tissue density maps overlaid on a brain volume. We include renderings for
both analytically and experimentally obtained p-values overlaid on the T1-brain image. It
can be seen from these images that the experimental and analytic p-value maps are at least
visually indistinguishable. Based on our simulated experiments we interpret regions with
lower p-values (higher -log(p-values)) to be more important to the classification function.
Regions identified by thresholding the p-value map using the Benjamini-Yekutieli proce-
dure at a q-value (Benjamini and Hochberg, 1995) of 0.1 are shown in figure 27. Regions
discovered with q-value thresholds of 0.01,0.05 and 0.1 are shown in figure 28. Note that for
FDR ≤0.1 the hippocampus, temporal cortex, the precuneus and the orbito-frontal cortex
are all detected as regions relevant to SVM based classification. This is consistent with
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Figure 26: Visual comparison of experimentally (left) vs analytically (right) generated -
log(p-value) maps using RAVENS maps data from ADNI
Figure 27: Regions detected after applying multiple comparisons corrections using the
Benjamini-Yekutieli procedure at q ≤ 0.1
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Figure 28: Regions detected after applying multiple comparisons corrections using the
Benjamini-Yekutieli procedure at q ≤ 0.01 (top row) ,q ≤ 0.05 (middle row) and q ≤ 0.1
(bottom row)
Figure 29: Regions detected after applying multiple comparisons corrections using the Bon-
ferroni correction at α = 0.05
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neuroanatomical and neurofunctional literature relating to Alzheimer’s disease pathology.
At FDR≤0.01 the procedure is extremely conservative but it still detects small sub regions
of all of the above mentioned regions as significantly involved in the SVM prediction. Upon
thresholding the p-map using the Bonferroni procedure at α = 0.05 only the hippocampi
are highlighted (See figure 29). Despite the usefulness of the two corrected p-value maps we
surmise that the the negative log p-value maps of figure 26 provide for a better depiction of
the relative importance of different brain regions in relation to the SVM model. While fig-
ures 26, 27 and 29 provide a visual description of the SVM p-value maps on ADNI data, for
the sake of completeness we have included a more quantitative picture of the approximation
in the scatter plot presented in figure 31.
3.5.4. Experiments with ADNI data: Comparison with local uni-
variate analysis
As described in the introduction the primary focus of this work is to understand what
regions of the brain are utilized by a support vector machine model to deliver diagnostic
scores from imaging data. Thus, we are addressing the global multivariate paradigm and
asking the question: What network of interacting regions does this SVM model use to make
the diagnosis? This is slightly different from the local paradigm that is typically a subject
of more traditional local univariate analyses which is : Which specific regions differ between
two groups which are apriori known to be distinct?
The SVM models are thought to utilize global structural or functional imaging patterns
to differentiate between groups. Thus, SVM based analyses may be suitable to identify a
network of regions that acts synergistically to manifest a group difference. In contrast local
univariate analyses may be more suitable to identify how a specific region differs between
two groups. Thus, there is an inherent complementarity between these two types of analyses.
We demonstrate this complementarity by comparing the result of a univariate analyses to
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Figure 30: Complementary nature of SVM based analysis and univariate analysis (left)
scatter plot of p-values obtained from univariate and multivariate analyses (right)
that of the proposed multivariate analyses on ADNI data in figure 30.
The univariate p-value map shown in figure 30 is generated by performing two sample t-
tests between the grey matter tissue density values at individual voxels. The analytical
approximation to permutation testing is used to generate the SVM based p-value map. A
scatter plot comparing p-values obtained from the two analyses is also included in figure
30. The scatter plot shows that the two p-value maps are distinct. Some regions such
as the hippocampi are significant according to both p-value maps. However, some other
regions such as the orbito-frontal lobes are better highlighted in the SVM based map. Other
regions in the temporal lobe are seen more clearly in univariate analysis. These results are
not necessarily novel, but are simply presented here as a confirmation of the the view that
local univariate analyses and global SVM based multivariate analyses offer complementary
information for population based statistical analysis.
Further, it is also important to remember that the multivariate analysis presented here
is focussed on interpreting the SVM model. Thus, we might say that the SVM uses a
global pattern involving the hippocampus in combination with the highlighted regions of
the orbito-frontal cortex to make its predictions. This, the SVM does despite the fact that
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Figure 31: Scatter plots comparing actual permutation testing with analytical approxima-
tion
the univariate voxelwise differences between patients and controls in this region are not as
strong as some other regions in the temporal lobe.
Thus, we may interpret, to successfully achieve better separation between controls and
patients in a multivariate sense, the SVM model relied not only on the hippocampus and
the temporal lobe but also on the orbito-frontal regions. Further, the SVM leave one out
cross-validation accuracy of 87% gives us an idea of the predictive power of the highlighted
multivariate pattern. As such there is no comparable measure to cross-validation accuracy
in univariate analysis.
3.5.5. Quantitative analysis
We present scatter plots between experimental and analytical p-values in figure 31. The
approximation accuracy seems to be higher at the low and high p-value ranges. These
plots are based off the data used for generating figures 22, 23 and the ADNI data. The
convergence between the analytic p-values and the experimental ones as measured by the
average per voxel error is rapid. From figure 32 we can see that the average per voxel error
in the p-values does not change substantially whether one uses 500 permutations or 1000
permutations. It does change substantially if one uses 100 permutations rather than 50.
This was one of the factors behind choice of one thousand permutations for our experiments.
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Figure 32: Convergence of the analytical approximation to experimental permutation tests
Figure 33: Variation of approximation error at low p-values with number of permutations
To investigate the behaviour of the approximation at ultra low p-values, we plot the negative
logarithm of experimentally obtained p-values against their analytic counterparts in figure
33 using simulated data (that was also used for generating figure 22). At first glance it
seems that the approximation is worse for low p-values and this seems like a limitation of
the approximation itself. However, if one repeats the experiment with the use of successively
larger number of permutations to obtain the experimental p-value maps a different picture
emerges. The approximation error at low p-values is lower as the number of permutations
used for generating experimental p-value maps is increased. Thus, the errors at low p-values
are possibly a limitation of our inability to perform a large enough number of permutation
tests as opposed to a limitation of the approximation itself.
To understand how the accuracy of this approximation decays with factors such as di-
mensionality, sample size and number of permutations we can use the fact that sj can be
expressed as a function of wj and w
Tw.
sj = f(wj ,w
Tw) =
wj
wTw
(3.20)
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Then if ∆wj is the uncertainity in estimating wj we can use error propagation theory to
deduce:
(∆sj)
2 ≈ (∂wjf)2(∆wj)2 + (∂wTwf)2(∆wTw)2 + cross terms (3.21)
Ignoring, the higher order terms we get:
(
∆sj
sj
)2
=
[(
∆wj
wj
)2
+
(
∆wTw
wTw
)2]
>
(
∆wj
wj
)2
(3.22)
Thus the relative error in approximating sj is larger than that of approximating wj alone.
The above expression provides a relationship between the approximation error on sj and
wj . The behavior of the approximation error on p-values generated using the wj (as com-
pared to actual permutations) has been documented in chapter 1. Any increase in error in
approximating components of w will produce a monotonic increase in the approximation
error of sj . Thus, factors such as a lower dimensionality and lower sample size which can
increase the approximation error of wj , automatically lead to a corresponding increase in
approximation error for sj . Also, based on (3.22) the increase in relative error for sj will
be larger than the corresponding increase in relative error for wj . Consequently, we would
expect the error in approximation of the p-value maps to be larger for maps based on sj as
compared to those based on wj .
3.6. Applications
In this section we present p-value maps generated by applying our SVM based inference
framework to several real imaging datasets.
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3.7. Application to major depressive disorder data
The dataset used for this experiment consisted of 23 patients with Major Depressive Disorder
and 20 healthy controls matched for age, gender and IQ. Patients with MDD assessed
with the Structured Clinical Interview for DSM-IV Axis I disorders (SCID-IV First et al.
(2012)). met criteria for single or repeated episode MDD repeated episodes MDD without
psychotic features as defined by Diagnostic Statistical Manual of Mental Disorders, Fourth
edition, text revision (Association et al., 2000). Healthy controls were screened to ensure
that they did not meet criteria for any mental disorders based on SCID-IV. MRI scans
were acquired on a 3.0 T GE SIGNA HDx (Milwaukee, USA) at Kings College London.
Image preprocessing was done to obtain grey matter and white matter RAVENS maps in
a manner similar to the ADNI dataset. An SVM classification model trained using white
matter RAVENS map data yielded a leave one out cross validation accuracy of 67.44% and
an AUC of 0.71. Inference using p-value maps computed using the theory presented in
this chapter are shown in figures 34 and 35. The regions used by the classifier have been
previously implicated in literature relating to depression.
3.8. Application to schizophrenia data
We applied our method to analyze an SVM model trained on data from a study compar-
ing controls to schizophrenia patients. The subjects of this study were recruited at the
Department of Psychiatry and Psychotherapy at Ludwig-Maximilians University, Munich,
Germany, and included 163 patients with an established DSM-IV diagnosis of schizophrenia
and 163 matched normal controls (NC).
All participants provided their written informed consent prior to MRI and clinical examina-
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Figure 34: p map showing white matter regions after thresholding to p < 0.05 The white
matter regions that showed highest contribution towards group difference were bilateral
cerebellar and occipital regions, left parietal and right frontal lobes
Figure 35: Bilateral cerebellar and occipital and right frontal regions (all p < 0.05)
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tion. Patient recruitment was performed by trained clinical investigators and consisted of a
structured clinical interview for DSM-IV-axis I disorders (SCID-I), a standardized clinical
interview for the assessment of medical and psychiatric history. All subjects were diagnosed
based on a consensus between 2 experienced psychiatrists who used the DSM-IV criteria
and the SCID-I. Participants were excluded if they had other psychiatric and/or neurolog-
ical diseases, past or present regular alcohol abuse, and/or consumption of illicit drugs, as
well as past head trauma with loss of consciousness or electroconvulsive treatment.
T1-weighted 3D-magnetization-prepared rapid acquisition with gradient echo sequences
(repetition time, 11.6ms; echo time, 4.9ms; field of view, 230mm; matrix, 512x512x126,
contiguous axial slices of 1.5mm thickness; voxel size, 0.45x0.45x1.5mm) were acquired on
a 1.5 T Magnetom Vision scanner (Siemens, Erlangen, Germany). The images were first
preprocessed by means of the VBM8 toolbox (publiclly available at http://dbm.neuro.uni-
jena.de/vbm8/)an extension of the Statistical Parametric Mapping software (SPM, pub-
lically available at http://www.fil.ion.ucl.ac.uk/spm/software/spm8/) for skull stripping,
bias correction, and segmentation (Ashburner and Friston, 2005). The skull-removed par-
tial volume estimation images were then spatially registered to the respective partial volume
image of the single-subject Monteal Neurological Institute (MNI) template through a ro-
bust method for elastic registration called deformable registration via attribute matching
and mutual-saliency weighting (Ou et al., 2011). The deformation field resulting from this
spatial registration was then applied to the segmented images in order to generate RAVENS
maps of the gray matter (GM), white matter, and cerebrospinal fluid segments. In these
RAVENS maps, the tissue density reflects the amount of tissue present in each subjects
image at a given location after mapping to the standardized template space.
Subsequently an SVM model was trained on the grey matter RAVENS maps (5-fold cross
validation accuracy 69.63%). The p-value map associated with this model has extremely
low values bilaterally in regions of the orbito-frontal cortices and the cerebellum. Sections
through this map are shown in figure 36.
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Figure 36: Regions with low p-values associated with SVM model trained on schizophrenia
data
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3.9. Application to the Baltimore Longitudinal study of
aging
The Baltimore Longitudinal study of aging (BLSA) has been prospectively collecting mul-
tidisciplinary data related to physical and psychological aging since 1958. Its neuroimaging
component, currently has followed approximately 160 individuals (aged 55 to 85 years at
enrollment) with annual or semiannual imaging and clinical evaluations. The neuroimag-
ing sub-study of the BLSA, which controls for consistency of imaging data over time, is
described in detail in Resnick et al. (2003).
We used T1-weighted MR images to measure regional patterns of brain atrophy using
RAVENS maps. The image acquisition parameters have been described in Resnick et al.
(2000). The BLSA protocol included an axial T1-weighted volumetric spoiled gradient
recalled (SPGR) series (axial acquisition, 1.5 T, repetition time (TR)=35 ms, echo time
(TE) = 5 ms, flip angle = 45, voxel dimensions of 0.94x0.94x1.5 mm slice thickness). All
scans were acquired on one of three GE (Schenectady, NY, USA) Signa 1.5 T scanners with
similar operating systems.
Image preprocessing involved (1) alignment to the AC-PC (anterior commissure-posterior
commissure) plane; (2) removal of extracranial material (skull-stripping) and cerebellum;
(3) N3 bias correction (Sled et al., 1998); (4) tissue segmentation into gray matter (GM),
white matter (WM), cerebrospinal fluid (CSF), and ventricles (Pham and Prince, 1999);
(5) high-dimensional image warping (Shen and Davatzikos, 2002) to a brain atlas (tem-
plate) (MacDonald et al., 2000) in the Montreal Neurological Institute (MNI) standardized
coordinate system; and (6) formation of regional volumetric RAVENS maps, generated to
enable analyses of volume data rather than raw structural data.
Ultimately, we trained a support vector classifier on grey matter and white matter RAVENS
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Figure 37: Regions with low p-values associated with SVM model trained on grey matter
RAVENS map based classification of the sexes using BLSA data. Periventricular grey
matter seems is prominently picked up by the model in addition to several cortical regions
maps to differentiate the gender between 53 females 70 males. The study is longitudinal,
and acquired data from each subject over multiple time points. In experiments presented
here we chose to use only RAVENS maps generated from data acquired from the first time
point. The rationale behind this choice was that SVM theory assumes that data points
are independent. Including scans of the same subject over multiple time points would
violate this assumption. Grey matter RAVENS based classification yields a 5-fold cross
validation accuracy of 81.3% for classifying males vs females. White matter RAVENS based
classification yields a 5-fold cross validation accuracy of 80.5%. p-value maps associated
with each SVM model are shown in figures 37 and 38.
93
Figure 38: Regions with low p-values associated with SVM model trained on white matter
RAVENS maps obtained from BLSA. White matter changes in the corpus callosum and
adjacent to it are most prominently picked up by the model.
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3.10. Conclusion
In conclusion, we have presented work that improves upon the statistical framework for in-
terpretation of support vector machine models presented in the previous chapter. Our new
framework explicitly incorporates the fact that SVM classification with a higher margin is
superior to SVM classification with a lower margin. We have shown using simulated data
that the margin based statistic alleviates certain shortcomings associated with the original
weight based statistics. We have also shown that null distributions associated with this
margin based statistic are normal. The proposed framework provides a statistical p-value
maps for interpretation of SVM models in neuroimaging. These p-value maps make SVM
based multivariate inference as accessible to use as VBM based univariate inference. They
also provide a multivariate view of the phenomenon under investigation that is complemen-
tary to univariate analysis. While the speed up provided by the approximation is important
, the fact that the null distributions associated with the statistics are asymptotically normal
is also very important. The gaussianity of the proposed statistics, opens up a whole world
of statistical properties, tests and analyses predicated on the gaussianity assumption. All of
this theory can be brought to bear for understanding SVM models. To illustrate practical
applications of our framework we have presented p-value maps associated with SVM mod-
els trained on data from several different imaging studies. Further discussion on potential
extensions and applications of this framework is presented in the Conclusions chapter.
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CHAPTER 4
Unsupervised machine learning for
the analysis of heterogeneity in
population neuroimaging : Clustering
for heterogeneity analysis and
mapping (CHAMP)
4.1. Introduction
The previous two chapters of this thesis have primarily focused on multivariate pattern
analysis (MVPA) in neuroimaging using the SVM, a widely used supervised classification
tool. We provided a mathematically rigorous interpretation of SVM models for neuroimag-
ing using statistical p-values. In doing so, we showed that the SVM model uses a single
brain wide pattern of differences to drive diagnosis/classification. In general, this search for
a single pattern of imaging difference that differentiates phenotypically distinct populations
is a common feature of other MVPA methods as well. Thus, all these analyses techniques
implicitly make an assumption that ‘single imaging pattern can distinguish between clini-
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cally distinct populations’.
Incidentally, this is also the driving assumption behind the most widely used univariate
methods for neuroimaging analyses. As explained in chapter 1, voxel-based morphometry
(VBM Ashburner and Friston (2000)), and its extensions (Chung et al., 2001; Davatzikos
et al., 2001), rely on univariate two sample t-tests comparing voxel-wise measurements
between two populations. In doing so, they search for a single image-wide pattern that
quantifies group difference between the two populations.
However, many neurological, neurodevelopmental, and neuropsychiatric disorders have a
substantially heterogeneous clinical presentation (Kramer and Miller, 2000; Dickerson et al.,
2011; Butters et al., 1996; Tsuang, 1975; Steen et al., 2006; Durston, 2003; Shiino et al.,
2006). Given this heterogeneity, the complexity of the human brain and the subjectivity of
clinical scoring it is unlikely that real diseases are driven by a homogeneous pattern of brain
deficit. Mounting evidence from clinical studies points the other way. In fact, it is very much
conceivable that multiple patterns of brain deficits drive the complex and heterogeneous
symptomatology of most neuropsychiatric diseases. Thus, there is need for neuroimaging
analysis tools that can search for multiple imaging difference patterns associated with a
specific population wide clinical difference.
While traditional parametric statistical approaches do not readily yield themselves to the
analysis of heterogeneity associated with population wide group differences, modern machine
learning methods do. Towards this end, we propose, in this chapter, an alternate strategy
for case-control analysis of neuroimaging data which allows for multiple patterns of brain
changes to be associated with a population wide group difference (figure 39). This is a
fundamental improvement over the work presented in previous chapters.
The framework we propose draws heavily upon concepts in existing econometrics literature
on matching estimators (Todd, 2008). In order to apply unsupervised machine learning
methods to the analysis of heterogeneity one needs to be able to first quantify individual
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Figure 39: Difference between traditional neuroimaging analysis paradigm used by
VBM/MVPA from heterogeneity analysis proposed in this chapter.
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specific effects of a given disorder. In the theory of matching estimators this is done by
assuming that every individual in the study can exist in two states, either as a ‘case’
or as a ‘control’. In any dataset collected by a clinical neuroimaging study, only one of
these outcomes can be actually observed. However, assessing the impact of a physiological
process driving a population-wide phenotypic difference requires us to infer what ‘case’
images would look like had they been observed in the ‘control’ population. The theory
of univariate matching estimators provides several specific procedures for achieving this
end. We develop a high dimensional analog of the simplest of these matching procedures,
namely the nearest neighbor matching estimator. We use the high dimensional nearest
neighbor matching estimator to quantify individual specific effects of disease. Then, we
apply unsupervised learning (or clustering) to summarize the effects of disease into a few
representative patterns of deficit measured by imaging.
In summary, the primary aim of this chapter is to present a framework that urges the
neuroimaging community to ask the question, “How many and what patterns of imaging
differences can we identify between two groups?” instead of the question, “By what sin-
gle pattern do two groups differ?”. We present clustering for heterogeneity analysis and
mapping (CHAMP) a methodological framework that systematically addresses the afore-
mentioned question and characterizes the heterogeneity of difference between two groups of
brain images. Although our experiments are based on identifying group differences in brain
structure, CHAMP is a general method that can be used in a broader spectrum of imaging
analyses.
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4.2. Why to use unsupervised analysis for population
neuroimaging: Heterogeneity in neurological disor-
ders
The diagnosis of neuropsychiatric disorders is currently made based on standards set forth
in the Diagnostic and Statistical Manual of Mental Disorders (DSM 5). The criteria set
forth in this manual are mostly based on patient responses to clinical interviews rather than
on a specific neurobiological or neuroimaging basis. For instance, a diagnosis of depression
may be based on a constellation of symptoms such as loss of appetite, loss of pleasure in
formerly pleasurable activity, sleep loss, and a general feeling of depression for more than
two weeks. Clearly, this is a rather nebulous constellation of signs and symptoms. The
population of individuals meeting these criteria will be quite heterogeneous (Nikolcheva
et al., 2011). When neuroimaging studies recruit patients based on these complex criteria,
the data collected must automatically reflect the inherent heterogeneity of the diseased
population.
Thus, heterogeneous imaging phenotypes associated with neuropsychiatric disease have been
reported in several studies. For instance (Noh et al., 2014) divided early stages of of AD
dementia into, medial temporal-dominant atrophy, parietal-dominant subtype and diffuse
atrophy subtype. Similarly, (Sauer, 2012) reviews brain imaging morphometry studies ad-
dressing the issue of heterogeneity within the diagnostic category of schizophrenia. They
implicate three different patterns of deficit all of which show an overlap in frontal changes
but diverge in terms of structural deficits in other areas such as the thalamus, hippocampus,
or cerebellum. In a similar spirit (Lenroot and Yeung, 2013) discuss imaging heterogeneity
in autism and (Dosenbach et al., 2013) present evidence for imaging based heterogeneity in
attention deficit and hyperactivity disorder (ADHD). Altogether, these studies demonstrate
that brain structure is not a uniform endophenotype for any neuropsychiatric disorder. In
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fact several distinct combinations of regional deficits may be the primary characteristic of
disease.
Thus, one of the key challenges to the development of neuroimaging analyses tools for
neuropsychiatric disorders is allowing for this ‘heterogeneity’ of disease. Addressing this
challenge in a principled manner using imaging can substantially further our understanding
of these diseases and provide information that may better reflect the underlying biology as
compared to symptoms defined by the DSM. This is the key challenge addressed in this
chapter.
4.3. The key challenge: Heterogeneity analysis in the
presence of confounding variation
The main purpose of this chapter is to present an approach to answering the question: “In
how many different ways (patterns) does group 2 differ from group 1?”. We propose to
answer this question by clustering imaging-based measures of differences between the two
groups under comparison: ‘group 1’ and ‘group 2.’ Figure 40 provides a visual illustration
of the rationale behind our question and the challenges involved in addressing it. In the
cartoon presented in Figure 40, size variation is present in both (green and blue) groups.
However, color variation is exclusive to group 2, reflecting that there are two patterns of
difference between groups 1 and 2 (blue vs light green, and blue vs. dark green). We
wish to develop an analysis technique that highlights each of these patterns of difference
individually. It is simple enough to see that comparing the images using voxel-based analysis
or generic MVPA methods will not achieve this end. A possible alternative would be to
use unsupervised analysis of the cartoons in group 2. However, this might not always
achieve this end either. More complex approaches such as principal components analysis
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Figure 40: Rationale behind clustering differences between the groups instead of data from
the groups themselves. We wish to design a simple method which can tell us that group 2
in this cartoon differs from group 1 in color, and that there are two such differences (dark
green vs blue, and light green vs. blue). Standard analytic approaches that search for a
single pattern of difference between these groups cannot achieve this. If we directly cluster
the images in group 2 we might get clusters based largely on the size of the cartoon as
opposed to the group difference. Thus, the need for difference-based heterogeneity analysis
tools like CHAMP.
might yield directions of variation that capture the heterogeneity in color, but these too
latch onto every possible source of variation in group 2. What we need, is an approach
that highlights the variation in the differences between the two groups while suppressing
variation that is common to both the groups. Undoubtedly, there exist several methods that
may be used to approach this question. CHAMP as presented here, offers but one possible
solution to this veritably complex problem. In the next section, we develop CHAMP in
the context of neuroimaging analyses. It should be noted that the questions asked and the
concepts presented are much more generic. As such, they may be applied to the analysis of
group differences in other biological data as well.
102
4.4. Addressing the challenge: The approach
4.4.0.1. Overview and notations
For the remainder of this manuscript we use the following standard set of notations. The
dataset contains m1 appropriately processed brain images from group 1, and m2 such images
from group 2. We wish to analyze heterogeneity in group 2 with respect to group 1. Without
loss of generality, we assume a vector representation of three dimensional images. Such a
representation may be generated by concatenating voxel intensity values into a single long
vector of dimensionality equal to the total number of image voxels (d). Keeping with this
notation, we index the vectors associated with images of the first group with j as x1j ∈ R1×d
where j ∈ {1, · · ·m1}. Vectors associated with group 2 images are denoted as x2i ∈ R1×d and
indexed by i ∈ {1, · · ·m2}. One may stack all the vectors associated with the first group
into a matrix denoted by X1 ∈ Rm1×d and vectors from group 2 into a matrix denoted
by X2 ∈ Rm2×d. In addition to imaging data, most clinical studies collect a large set of
ancillary clinical variables as well. Examples of such variables may be age, sex, ethnicity,
scanner types, and even the concomitant presence or absence of another disease. CHAMP
uses a sub set of these ancillary variables that are a) distributed independently of the group
labeling under study and b)have a substantial influence on brain anatomy and function.
A prime example of such a variable might be ‘age’ in an ‘age-matched’ imaging study.
Knowledge of a subject’s age gives us no additional information about it’s group label in
such a study. Yet, it’s influence on brain anatomy is undeniable. We call such a variable
a ‘meta-variable’ and matching subjects between groups using these ‘meta-variables’ is the
basis of the CHAMP approach. We denote the collection meta-variables associated with
x1j in the vector v
1
j and meta-variables associated with x
2
i with v
2
i . These meta-variable
vectors may be assumed to be multi-dimensional, but their dimensionality is assumed to be
much lower than the sample size of the study.
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4.4.1. The difference representation matrix
As stated earlier, we aim to identify heterogeneous patterns in X2 that are not concomitantly
present in X1, and are associated with the differences between groups 1 and 2. We operate
under the assumption that the majority of such variation is driven by the group difference
itself. Here, we propose to encapsulate this variation into a difference representation matrix,
denoted by D ∈ Rm2×d. The subsequent text presents a procedure to construct such a
matrix alongside the intuition behind this procedure.
Assume p(x1) and p(x2) to be probability distributions associated with groups 1 and 2.
Recall that we chose meta-variable distribution to be independent of group labeling. Thus,
if we assume p(v) to denote the distribution from which meta-variables are sampled, then
we may write:
p(x1) =
∫
v∈V
p(x1|v)p(v)dv (4.1)
and
p(x2) =
∫
v∈V
p(x2|v)p(v)dv (4.2)
where V indicates the domain of v. In the expressions above we may be able to model
p(v) using data. However, it is nearly impossible to estimate the distributions p(x1|v)
and p(x2|v) from sample sizes typically available in neuroimaging studies. This is because
imaging data are high dimensional in nature. Yet, we use these conditional distributions to
elucidate certain concepts that are critical in the design of our method.
Consider, x2i ∼ p(x2) to be a subject that was observed in group 2. Define x1j(i) ∼ p(x
1)
to be the image that would have been observed for subject i if, contrary to fact, subject
i had been observed in group 1. That is, we would have observed x1j(i) had this subject
been spared of the pathological process that drove subjects from group 1 to group 2. In the
statistics and causal inference literature, x1j(i) is referred to as a counterfactual or potential
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outcome Rubin (1974) Holland (1986) Rubin (2005).
Under certain assumptions, it is possible to obtain a reasonable estimate of x1j(i) using the
observed data from group 1. First, as previously mentioned, we must assume that v arises
from common distribution p(v) for both groups. Second, we must assume most or all of the
variation in the images beyond that caused by the disease itself is captured by v. When
these assumptions hold, x1j(i) can be estimated using data from patient group 1. Next, we
outline our proposed approach for estimating x1j(i) for each patient.
In this work, we propose to model x1j(i) as the mean of the conditional distribution p(x
1|v =
v2i ). The intuition behind using such an estimation is that meta-variables like age and sex
provide a fairly low dimensional measure that captures a large proportion of variation in
normal brain anatomy. Like the size of the cartoon in figure 1, the variation captured by
meta-variables is assumed to be common across the populations being compared. Thus, the
mean of p(x1|v = v2i ) provides a reasonable estimate of how the true x1j(i) might look like.
Formally, one may write:
x1j(i) =
∫
x1∈X1
x1p(x1|v = vi2)dx1, (4.3)
where the integration only uses the subset of x1 that has meta-variable values which match
vi2. This definition of x
1
j(i) is based on a distribution that is conditioned on the meta-data
rather than the full distribution of the imaging data themselves.
Now in real data, sample size constraints severely limit the total number of samples with
v = vi2. So we estimate x
1
j(i) using the mean of r samples chosen from group 1 which have
meta-variable values closest to vi2 in a Euclidean sense. If we let l ∈ Si index this set of r
samples for a particular x2i , then we may approximate x
1
j(i) as:
x̂1j(i) =
1
r
∑
l∈Si
x1l . (4.4)
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The expression on the right of the above expression represents our best estimate of x1j(i).
Using our estimate of x1j(i), we may finally compute:
di = x
2
i − x̂1j(i). (4.5)
This vector represents our best guess of the component of x2i that arises from phenom-
ena driving the group difference. Thus, the distributional assumptions made above ul-
timately lead to a construction of di that is based on nearest ‘group 1’ neighbors of x
2
i
where,‘nearness’ is defined using meta-data rather than the imaging itself. This contrasts
the traditional machine learning perspective, where feature vectors themselves are used to
define ‘nearness’. The intuition behind this meta-variable centric approach may be exem-
plified by considering the following scenario. Suppose, we were analyzing imaging data
from a study comparing autistics to normal controls. If a six year old male autistic child
did not have autism, his brain should look like a six year old normal male child. It would
be incorrect to assume that a 6 year old autistic male brain would look like to a 4 year
old normal female brain if autism never manifested. The invalidity of such an assumption
would hold in spite of any observed similarity in terms of brain structure/imaging.
This idea is presented visually in figures 41 and 46 and captured in the theory presented
here. Thus, we use meta-variable based neighborhoods to compute the vectors di for all
i ∈ {1, · · · ,m2} and stack them row-wise to construct the matrix D. We theorize that this
matrix exposes variation associated with group differences.
Heterogeneity visualization and mapping
The study of heterogeneity using the difference vectors di is the search for clusters of self
similar difference vectors. A re-ordered cross-correlations matrix-based approach may be
used to visualize similarity between the rows of D. While it is the similarity between the
rows of the matrix that we need to capitalize on, no additional information is conveyed by
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Figure 41: Group differences are most likely expressed as changes in voxel intensity in case
of imaging data. Thus, if group 2 was essentially generated by subtracting or adding a fixed
number to the intensities in group 1, neighborhoods based on Euclidean distances would not
generate appropriate difference maps. In the illustrations above the orange ellipses indicate
Euclidean distance based neighbors, whereas the black arrows indicate the neighbors we
want to find.
the extremely high similarity of every row with itself. With this in mind, we compute the
hollow matrix F ∈ Rm2×m2 with elements given by:
Fpq = (1− δpq)Kpq, (4.6)
where the matrix K is defined as: K = DDT and δpq is the Kronecker delta symbol. Using
the rows of F as features in a k-means algorithm we define cluster memberships that define
sub groups of group 2. In order to understand how each of these subgroups differs from
group 1, we run voxelwise univariate analysis between each subgroup and group 1. We
visualize the resulting p-value maps by overlaying them on a template brain.
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4.5. Experiments and results
In this section we present results generated by applying CHAMP on the ADNI dataset.
We used controls as group 1 and patients as group 2 for our experiments. Thus, we have
used CHAMP to investigate heterogeneity in patients with respect to controls. Age and sex
are used as meta-variables. The dataset we use contains 100 controls and 100 Alzheimer’s
patients. We show results for various different parameter settings of the method. We discuss
these results and contrast them with other plausible approaches to heterogeneity analysis
in the discussion at the end of the chapter.
4.5.1. Data preprocessing for ADNI
Raw ADNI data from the ADNI-1 study was used for all experiments presented in this work.
The data was bias corrected with N3 and skull stripped using multi-atlas skull stripping
(MASS Doshi et al. (2013)). This was followed by segmentation into three tissue types:
gray matter (GM), white matter (WM), and ventricles (VN) using MICO (Li et al., 2014).
DRAMMS (Ou et al., 2011) registration was run to register each subject to a common
template. Tissue density maps were generated from the resulting deformation fields using
the RAVENS (Davatzikos et al., 2001) approach. We exclusively use GM tissue density
maps (GM-RAVENS) in the present work.
4.5.2. Results using simulated data
Before applying the method to the actual ADNI data we demonstrate its validity by using
it on simulated data with known ground truth. The data simulations were performed using
imaging data from control subjects drawn from the ADNI study. We divided these data
108
into two equal groups: simulated controls and simulated patients. We introduced two sep-
arate patterns of atrophy in the simulated patient group by reducing the intensity of the
tissue density maps in specific locations by fifty percent. These ground truth patterns of
atrophy are shown in figure 42. The first pattern of atrophy was introduced in half of the
simulated patients and the second pattern in the other half. These patterns were meant
to mimic heterogeneous effects of disease. In addition to the two patterns of atrophy, we
also introduced a global reduction of GM tissue density values linked with a randomly gen-
erated meta-variable. The association between the randomly generated meta-variable and
percent reduction of atrophy was quadratic. This meta-variable, and the associated global
simulated reduction of tissue density values was intended to mimic the highly nonlinear and
multivariate effects of similar meta-variables (like age) in real neuroimaging data. These
simulations are naive in comparison to the formidable complexity that is likely to underlie
the effects of disease, age, sex, ethnicity, or any other such variables in real data. However,
the simulations did allow us to 1) validate our methodology and 2) provide interesting in-
sights into the workings of this method. CHAMP could successfully detect the simulated
clusters in this data. VBM comparison of each cluster (produced by CHAMP) to simulated
controls clearly delineates the two distinct patterns of simulated atrophy, present in the
data. The results are summarized in Figure 42. Similar results can be obtained for either
a 40% or a 30% reduction in gray matter tissue density.
4.5.3. Results from ADNI
We applied CHAMP to investigate heterogeneity of brain atrophy in AD, using data from
the ADNI. Recall that the two parameters involved in applying CHAMP include a) r - the
number of neighbors from group 1 used in the modeling, and b) k the number of clusters
the patient group is divided into.
In what follows we highlight how clusters produced by CHAMP using different parameter
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Figure 42: The leftmost column shows the regions where the atrophy was simulated by
reducing tissue density maps by 50%. The next column shows that p-value maps generated
by CHAMP can be used to identify regions of simulated deficit in the imaging data. The
two rightmost columns show that a re-ordered F matrix generated using the difference maps
is reflective of the latent structure of disease heterogeneity. This is not true if the original
data are themselves used to generate this image.
values might be reflective of processes traditionally measured using clinical scores. Towards
this end, we investigate CHAMP clusters with respect to scores generated using the mini
mental state examination (MMSE). The MMSE (Folstein et al., 1975) standard verbal test
is based on a 30 point questionnaire, and it is used extensively in clinical and research set-
tings to measure cognitive impairment (Pangman et al., 2000) and to diagnose Alzheimer’s
dementia. Scores greater than or equal to 27 points indicate normal cognition. Scores below
27 indicate cognitive impairment. The lower this score, the worse the dementia.
Figures 43 and 44 summarize results produced by CHAMP using ADNI data and parameter
values r = 10 and k = 2. The two clusters produced by CHAMP differ significantly
in terms of MMSE. VBM based p-value maps quantifying the difference between each
cluster and controls are shown in figure 43. The two VBM maps differ from each other
substantially. The p-value map associated with the cluster with higher MMSE shows deficits
of the hippocampal and para-hippocampal regions alone. On the other hand, the map
associated with the cluster with lower MMSE scores shows difference in the hippocampus,
the entorhinal cortex and the precuneus. The differences between the clusters themselves
can be further elucidated by running VBM to explore imaging-based differences between
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Figure 43: Cluster 1 is significantly different from the controls in the hippocampus and the
parahippocampal GM regions. Cluster 2 shows strong deficits in the hippocampal regions,
the precuneus and the entorhinal cortices.
these two clusters. The associated p-value maps are shown in figure 45. Note that the
patient subgroups generated by CHAMP differ significantly in terms of the MMSE, but
they do not significantly differ with respect to age, implying that the effects elucidated by
the method are not reflective of aging itself, but rather of the disease process, and that this
process seems to be relatively invariant to age. In short, we show that, CHAMP produces
clinically distinct patient subgroups using imaging data, along with age and sex information.
Figure 44: Cluster 1 has significantly higher MMSE values as compared to cluster 2. How-
ever, the two clusters do not differ in terms of age.
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In order to highlight stability of CHAMP results with respect to perturbations in parameter
values, we compute CHAMP clusters using several different parameter settings and show
p-value maps and ANOVA plots corresponding each setting. Results generated using k = 3
and r = 10 are shown in figure 46. These show substantial difference between clusters
in terms of MMSE, but not in age. In fact the cluster associated with the p-value map
showing a deficits in a larger number of brain regions also corresponds to the cluster with
worse MMSE scores. When we perform CHAMP analysis with k = 4 and r = 10 the clusters
generated do not differ significantly in terms of age or MMSE (figure 47). This is despite
the fact that relatively familiar patterns do show up in the associated p-value maps. Based
on these results we chose not to proceed with values of k > 4. The results presented in
figures 43 through 47 give us valuable insight into variation of CHAMP results with respect
to number of clusters k. Next, we explore how the results vary with respect to variations
in ‘r’.
To do this we apply CHAMP by keeping k fixed at 2 and varying r. This yields figures
48 and 49. p-value map patterns similar to those shown in Figure 43 appear. ANOVA
reveals differences between MMSE amongst the clusters generated without a corresponding
difference in age.
While the results presented thus far provide interesting insights into the workings of CHAMP
at various parameter settings, they do not provide a broad and objective evaluation of the
behavior of the method over a large range of parameters. However, understanding such
behavior is paramount in guiding parameter selection for heterogeneity analysis in a new
dataset. Towards this purpose, we use the following procedure. We generate CHAMP clus-
ters for values of r ranging from 2 to 30 and values of k ranging from 2 to 4. We perform
ANOVA to evaluate the difference between MMSE (and age), between clusters generated at
each setting. We plot the negative logarithm of the associated ANOVA p-values for every
possible parameter value in figures 50 to 52. These plots are discussed in more detail in the
subsequent ‘Discussions’ section of this chapter.
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Figure 45: First column shows p-value maps highlighting differences between clusters gen-
erated using CHAMP which uses the proposed method. Second column shows similar
differences generated using imaging-based difference maps. Third column shows ANOVA
measuring how MMSE/age differ between clusters generated using imaging-based difference
maps.
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Figure 46: CHAMP results generated from ADNI data using k=3 and r=10. Cluster
1 presents deficits mainly in the hippocampus, cluster 2 in the hippocampus and small
regions of the precuneus, cluster 3 and entorhinal cortex and hippocampus and precuneus.
The MMSE differs substantially between the three clusters while the age does not.
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Figure 47: CHAMP results generated from ADNI data using k=4 and r=10. While some
of the patterns are familiar the clusters do not differ amongst themselves in a statistically
significant manner.
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Figure 48: CHAMP results with number of nearest neighbors set (r) set to 8 and number
of clusters set to 2.
Figure 49: CHAMP results with number of nearest neighbors set (r) set to 12 and number
of clusters set to 2.
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Figure 50: Negative logarithm of ANOVA p-values associated with clusters generated by
CHAMP for various values of r and for k = 2.
Figure 51: Negative logarithm of ANOVA p-values associated with clusters generated by
CHAMP for various values of r and for k = 3.
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Figure 52: Negative logarithm of ANOVA p-values associated with clusters generated by
CHAMP for various values of r and for k = 4.
4.5.4. Experiments on ADNI comparing CHAMP to prior art
In this section we present experiments that expose the value of the CHAMP approach by
comparing it to existing image based heterogeneity analyses.
First we present an experiment comparing CHAMP difference map clustering to direct data
clustering itself. This clustering method was used in Noh et al. (2014). Towards this end
we perform data clustering using the grey matter RAVENS maps of patients. We compare
the resulting clusters with respect to age and MMSE. These results are presented in figure
53. The resulting clusters differ significantly in terms of age but not in terms of MMSE.
Next we present an experiment comparing CHAMP clusters to clusters generated using
‘image based’ difference maps. The latter approach forms the basis of the heterogeneity
analysis method proposed in Gaonkar et al. (2011). This approach estimates x1j(i) using r
controls closest to a chosen patient, as measured by the Euclidean distance between x2i and
vector representations of images from ‘group 1’. We set r to 10 and computed these ‘image
based difference maps’ using GM-RAVENS maps in ADNI data. Clustering was done with
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Figure 53: (Left) Illustration of why clustering ADNI data directly results in age based
clusters. (Right) Comparison of MMSE and age using clusters generated with the ADNI
patient data itself.
Figure 54: (Left) Why imaging based neighborhoods may not be appropriate for hetero-
geneity analysis. (Right) How imaging based neighborhoods are confounded by age in ADNI
data
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k = 2. The subgroups generated differ significantly in age but not MMSE. The associated
results are presented in figure 45, where they are also contrasted with CHAMP results for
the same parameter values.
Figure 45 shows why meta-data based difference maps should be used instead of image based
difference maps. The p-value maps show that clusters generated using ‘image-based differ-
ences’ differ from each other mainly in terms of peri-ventricular lesions. Peri-ventricular
lesions are a hallmark of dementia and aging and are not necessarily specific to Alzheimer’s
patients (Barber et al., 1999). Thus, these clusters mainly highlight the effect of aging.
This confirms the trend presented by the ANOVA in Figure 45. On the other hand, clus-
ters generated using CHAMP differ in the precuneus and the entorhinal cortex. Deficits
in both of these are known to be associated with Alzheimer’s disease (Karas et al., 2007;
Gómez-Isla et al., 1996). This highlights the value of using meta data for defining matches
prior to clustering in CHAMP.
4.6. Discussion
The method presented above is designed to highlight heterogeneity using neuroimaging data
from large case-control cohorts. The driving principle behind our analysis is the clustering
of differences between cases and controls. This is distinct from traditional approaches used
for the analysis of these data. Traditionally, analyses used in neuroimaging have been based
on methods assuming that the two groups differ by a single pattern, which is discovered via
ROI-, VBA-, or MVPA-based analyses. These emphasize homogeneous disease patterns,
or else find a “common denominator”. However, it is known that diseases affect each in-
dividual in a different manner, and that there is substantial heterogeneity in the clinical
presentation of any neurological disorder. Similarly, in fMRI task-activation studies, there
might be heterogeneity in how individuals respond to external stimuli. Structural and func-
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tional neuroimaging data present an unprecedented opportunity to quantitatively delineate
case sub-populations that differ from one another neurophysiologically, a variability that
CHAMP aims to tease out.
In what follows we discuss key concepts that form the basis of CHAMP. We discuss these
concepts in relation to experiments and results presented above.
4.6.1. Key concept of CHAMP analysis 1: Using difference maps
generated from data for clustering instead of using the data
directly
Majority of the contemporary literature attempting to explore disease heterogeneity using
imaging relies on either a) direct clustering of image data (Noh et al., 2014) or b) clinical
definition of heterogeneity (Kramer and Miller, 2000; Dickerson et al., 2011; Butters et al.,
1996). CHAMP uses a substantially different mechanism. It relies on clustering a data
driven estimate of an individual specific effect of disease. One can think of this individual
specific ‘disease effect’ as the high dimensional analog of the ‘treatment effect’ in the theory
of matching estimators. This high dimensional disease effect is the difference map used by
CHAMP.
The use of image difference maps to aggregate information related to population-wide group
separation using neuroimaging data is a novel aspect of CHAMP. CHAMP aggregates these
effects into a difference matrix which serves as a quantifier of the effects of a group difference
on a population. This is distinct from the theory of matching estimators, where all the effects
would be aggregated to obtain a mean effect.
This difference matrix is a unique and malleable representation of group difference informa-
tion which opens up a lot of avenues for future work. CHAMP clusters rows of this matrix
in order to explore disease heterogeneity using imaging. Quantitatively, the advantage of
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clustering image difference maps stored in the difference matrix as compared to images
themselves, can be seen by comparing figure 14 to figure 5. Clusters generated by using
the difference maps differ significantly in terms of MMSE and clusters generated using the
images differ in significantly in terms of age. This is encouraging since MMSE is a proven
measure dementia and differences in MMSE between patients with a similar age distribution
is a credible sign of disease heterogeneity.
4.6.2. Key concept of CHAMP analysis 2: Meta-data based dif-
ference maps versus image-based difference maps
CHAMP uses meta data for computing matches between the groups. Standard machine
learning techniques which form the foundation of neuroimaging MVPA-analysis use data
itself to compute ‘nearness’. In this sense CHAMP is fundamentally different from MVPA-
analyses which are considered state of the art in neuroimaging.
This makes it critical to make the right choice of meta-variables. It is this choice, rather
than the imaging data, that essentially drives the matching process. In this section we
present specific guidelines for picking these meta variables. To this end recall that the
difference maps employed by CHAMP are high dimensional analogs of ‘treatment effects’
in the theory of matching estimators. Thus, we surmise that we may use this theory for
guiding the selection of matching variables.
In line with this theory, we require that meta-variables used for matching be distributed
independently of group membership. That is knowledge of the distribution of these meta-
variables should not allow for prediction of group label. In general variables such as age,sex
and ethnicity fit this criterion well. We have also required that meta-variables encode for
a substantial degree of variation in the imaging data. For instance, age greatly influences
anatomy as does gender. On the other hand socio-economic meta variables such as income
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are unlikely to be associated with a similar degree of variation. Thus, matching based on
age is likely to generate a better estimate of difference maps as compared to matching on
incomes. A key exception to the use of age as a meta variable would be if one were trying
to study heterogeneity in aging itself. In such a case one would need to use a different set
of meta-variables. Possibly a combination of gender, ethnicity and heredity could achieve
the required effect. More generally, the choice of meta variables should be a study specific
decision and it must be made based on the specific aims of a given analysis. Thus, the
investigator has a critical role in ensuring the appropriate choice.
4.6.3. Parameter selection for CHAMP analyses
CHAMP requires the user to select two parameters namely, r - the number of matches used
to estimate the difference map and k - the number of clusters to generate.
Using a value of k which is very large may generate clusters containing small numbers of
patients. If a cluster contains less than 10% of the data, it is likely that it consists mostly of
outliers. Using k = 1 computes the mean of all the disease effects and yields p-value maps
that are similar to VBM analyses. In the work presented here we have chosen ‘k’ values
between 2 and 4. Using k > 4 yields clusters of low cardinality that are unlikely to yield
significant nosological constructs. Based on the ANOVA results shown in figures 5,7 and
8; k = 2, 3 seem to yield cluster memberships correlated with the MMSE score. When k is
increased to 4 two of the generated clusters present similar MMSE values and the overall
significance of the ANOVA drops.
The number of matches r used to model the effect of a phenotypic difference is the other
major parameter that must be selected before running CHAMP. Choosing a very small
value of r carries the risk of generating noisy estimates of x1j(i). Hence cluster memberships
generated using small values of r may not be reliable. On the other hand choosing, a very
large value of r implies that x1j(i) is very close to the mean of group 1 itself. In such a setting
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the clustering memberships are essentially based on the patient data rather than difference
maps. It is advisable to stay in between these two extremes while applying CHAMP analysis.
Results presented in figures 50 through 52 indicate that for values of r close to 10 CHAMP
clusters differ most significantly in terms of MMSE and least significantly in terms of age.
While there is no definitive trend at low values of r, at large values of r the ANOVA for
age starts becoming significant. This is in line with our intuition that the clustering mimics
clustering of raw patient data itself. Thus, we surmise that values of r close to 10 represent
a balanced approach that is most effective in highlighting disease heterogeneity.
The guidelines presented above along with plots analogous to figures 10 to 13 yield an
effective technique for parameter selection in a new data set. In the next section we conclude
this chapter with a brief summary.
4.7. Conclusion
In summary, this chapter presents CHAMP, a method for exploration of heterogeneity in
population neuroimaging studies. We have validated this method through experiments on
simulated data and also demonstrated a potential use case of the method by analyzing the
publicly available ADNI dataset. In the future, we hope that the neuroimaging community
develops this method further and applies it to a diverse array of biomedical data.
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CHAPTER 5
Conclusion
5.1. Summary
The aim of this dissertation was to address the problem of population wide neuroimaging
analysis from a high dimensional machine learning centric perspective. Machine learning
analyses enables the use of brain MR images to diagnose brain related disorders. How-
ever, these methods are often designed to act like black boxes. In this dissertation we have
explored both supervised and unsupervised machine learning methods and developed tech-
niques to connect the associated black box models with traditional interpretative statistics
such as p-values.
Specifically, in chapters 2 and 3, we have developed a p-value based interpretation for
support vector machine models. We have also presented applications of this framework
to interpret diagnostic / classification models learnt using data from several large scale
population studies. The availability of a p-value map in conjunction with a diagnostic
SVM model allows non specialists to understand how the model works in a mathematically
rigorous way. The availability of a p-value based inference mechanism is highly relevant,
given that a majority of the clinical and research training relies on p-value based inference.
We chose to focus on support vector machines because they are the most widely used
supervised machine learning tool in the domain of medical image analysis.
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The work presented in chapter 4, highlights the value of unsupervised machine learning
to population wide neuroimaging analyses. Unsupervised methods have rarely if ever been
used to directly quantify the difference between populations in neuroimaging. However, such
analyses can be extremely valuable in the study of several psychiatric disorders. We have
broached this topic using a simple framework in chapter 4. While the analyses presented in
the chapter relies a simplistic methodological framework, it does present an imaging based
approach to identify disease subtypes and understand heterogeneity in disease.
The following section presents oportunities for future methological work based on this dis-
sertation. We also present some preliminary results associated with this work.
5.2. Discussion and future work
5.2.1. SVM for detecting abnormalities
The inference framework developed for the support vector machine contains elements that
may be re-purposed for a slightly different problem in medical image analysis. Namely
the problem of delineating abnormalities. To see how this may be done, recall that the
SVM solves a convex optimization problem that uncovers a direction in hyperspace that
differentiates two point clouds with maximal margin. What would happen if we were to
force one of the point clouds to contain only one point? In such a case, the algorithm would
compute a direction that maximally differentiates this point from the other point cloud
(figure 55). The direction and the associated margin computed by the algorithm could
potentially be used for abnormality detection and even abnormality segmentation. In the
subsequent text, we explain how this could be achieved.
Let i ∈ {1, · · · , n} index a set of n normal controls. Also let xi denote vectorized image
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Figure 55: (Left) Typical support vector machine optimization with multiple control and
patient samples (Right) support vector machine optimization with a single patient and
many controls.
representations corresponding to these normal controls. In principle, one could apply the
leave one out paradigm and train n support vector machines. Each SVM would generate
a corresponding margin vector si quantifying how a specific control differs from the group.
Now the collection of vectors si for i ∈ {1, · · · , n} quantifies how each control image differs
from the rest of the group . We can use the theory presented in chapter 3 to estimate
the distribution of the si. If we let X to denote a matrix constituted as a stack of the
xi’s, then, we would expect the components of si to be distributed normally according to
equation (3.14). Given a vectorized image and a separating vector s∗ corresponding to a
new subject, abnormality detection requires us to answer two questions a) is this subject
abnormal and b) what is the location of the abnormality.
The first of these questions may be answered by appealing to the distribution of the mag-
nitude of sj . If the magnitude of s∗ denoted by ||s∗||2, is far larger than the magnitudes
of the vectors si, then it is likely that the new subject is not normal. On the other hand
if the value of ||s∗||2 is comparable to ||si||2, ∀i then it is likely that the new subject is
in fact a control. Doing this would require us to further develop the analytic framework
presented in chapter 3 with a focus on approximating the distribution of ||si||2. This is
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Figure 56: (Left) Illustration of proposed permutation procedure (Right) Expected margin
vector corresponding to a patient image
a complex endeavor because the associated distribution is unlikely to be normal and also
because it requires the estimation of the variance and expected value of a quadratic form
with a specialized but unknown co-variance structure.
The second question, may be answered using the framework presented in chapter 3 itself.
That is, given that a subject is ‘abnormal’, we may locate the abnormality by comparing
components of s∗ to the respective components of si. Since, the analytic form of the
distribution of these components has been worked out, we would expect this distribution to
be normal. Specifically, following the logic presented in chapters 2 and 3, we would expect:
E(sj) = 0 (5.1)
and
var
( wj
wTw
)
≈
σ2j[∑d
k=1 σ
2
k
]2 (5.2)
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Figure 57: Illustration showing the application of matrix factorization to difference matrix
data
with:
σ2j =
4(n− 1)
n2
m∑
i=1
C2ij (5.3)
with Cij being the components of C given by (2.12).
In combination, the two questions presented above and their respective answers, yield a
learning framework that could potentially turn the support vector machine based statistical
analysis framework into a learning based abnormality detection and segmentation engine.
Such an engine would mimic human radiologist training in that it could ‘learn’ a model
of ‘normalcy’ from control images and use this model to identify what is abnormal. The
prime advantage of such a mechanism over traditional segmentation techniques would be 1)
the ability to learn from ‘normals’ 2) a p-value based interpretation of results 3) improved
performance with an increased sample size of normal scans. We propose to develop this
approach to maturity in future work.
5.2.2. Dictionary learning for heterogeneity analysis
Heterogeneity analysis presented in chapter 4 relies ultimately on consensus k-means clus-
tering of a feature matrix to define patient clusters. We chose this approach because a)
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k-means is one of the simplest and well understood clustering algorithms and b) it produces
discrete cluster memberships for patients which can consequently be used to understand
what each patient subgroup represents. However, this overlooks the fact that every patient
may not neatly fall into one of the CHAMP ‘subgroups’ and it may in fact be expressing a
pattern of deficit that is some combination of the patterns associated with the two different
CHAMP clusters. In what follows we argue that the difference matrix representation used
by CHAMP in conjunction with advanced matrix factorization algorithms may provide a
powerful tool for understanding subject specific anatomical/functional effects of disease.
Recall that the difference matrix used by CHAMP is a representation of imaging group
difference information which is distinct from traditional t-statistic/p-value maps generated
by VBM (Ashburner and Friston, 2000) or SVM (Gaonkar and Davatzikos, 2013) analysis.
This factor differentiates the method from other group based analysis methods in literature.
The fact that CHAMP represents group differences as a matrix, opens up the possibility
of applying dictionary learning/matrix factorization methods to population-wide difference
analyses. Unlike k-means, such methods may be applied within the CHAMP paradigm
to yield soft clustering. This allows each individual to be a part of multiple clusters. To
understand this better first note that D ∈ Rm2×d where we stick to the notation from
chapter 4 with m2 as the number of patients and d as the number of voxels in the images.
We may decompose this matrix as:
D = LB (5.4)
where we will have L ∈ Rm2×k and B ∈ Rk×d. Here k is a parameter akin to the number
of clusters used in k-means. Rows of the matrix B are the dictionary learning equivalents
of ‘cluster centers’. This matrix is also known as the basis matrix is thought to uncover
latent structure in the data. The matrix L is the loadings matrix. The loadings matrix
defines how rows of B can combine to yield rows of D. We illustrate in figure 57 how matrix
factorization might be used to uncover latent patterns that combine to manifest disease in
a specific subject.
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Literature on matrix factorization approaches is vast and we do not do not detail it here.
However, we opine that sparse matrix factorization techniques should be most effective in
the context of heterogeneity analysis. In summary, the use of matrix factorization in place
of standard clustering presents the possibility that one could find a common set of base
patterns that summarizes the effect of disease in a population and a combination of such
base patterns could potentially delineate individual specific disease effects in a more concise
manner than the existing framework.
A substantial amount of methodological and experimental work is necessary to develop the
sparse matrix factorization idea into a mature approach. This is outside the scope of the
current work, but nevertheless remains a promising avenue of future research.
5.2.3. Improved matching for heterogeneity analysis
The construction of the matrix D in chapter 4 uses simple and intuitive meta-data based
nearest neighbor matching procedure. This procedure is simple and reveals interesting
insights about the data. However, it does require a) an intelligent choice of meta variables
and b) a careful selection of parameters before running the method. In the future both of
these aspects may be improved upon.
5.2.3.1. Meta variable selection using machine learning
While a researcher still has to exercise his or her intuition while selecting meta variables,
one may be able to guide the selection procedure by measuring how strongly each candidate
meta-variable is associated with variability in the data. One possible approach would in-
volve, learning a multivariate model to predict each meta-variable from imaging data. One
would expect the imaging data to be more predictive of meta-variables which encode for
a higher degree of variation. From this perspective, it is interesting to note that a sup-
port vector regression trained on the ADNI controls data does result in predictions that
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are highly correlated with the actual age in cross-validation. This indirectly points to the
fact that age might encode a large proportion of variance in the imaging data. Similar
claims may be made for gender information. This is not necessarily true of say, a randomly
generated meta-variable. Thus, machine learning techniques offer one possible approach to
automate or at least guide the selection of meta-variables. Other possibilities include (but
are not limited to) an aggregate measure of correlation between specific candidate meta-
variables and voxel intensity values or the correlation between candidate meta-variables and
the principal component loadings of the data. The apt choice of meta-variables is critical to
the success of the CHAMP approach. Thus, it is a subject of paramount importance and
should be a major thrust of future work.
5.2.3.2. Alternate matching schemes
Parameters used by the heterogeneity analysis in chapter 4 define how images get matched
across groups. The matching scheme proposed in the chapter is simplistic and ultimately
relies on a nearest neighbor matching. It is easy to imagine sophisticated versions of this
matching framework. The simplest modification would be to use a weighted matching. In
this case we would re-write equation (??) as:
x̂1j(i) =
∑
l∈Si
wlx
1
l . (5.5)
where wl would be appropriately chosen weights. The weights themselves may either be
explicitly specified on the basis of the meta-data or some combination of meta-data and
imaging. For instance, sticking to the notation in chapter 4, one could set wl to:
wl = e
γ||vi−vj(i)||2 (5.6)
where γ is an appropriately chosen constant. Such a weighting would estimate x1j(i) using a
linear combination of all group 1 images with highest weights assigned to group 1 subjects
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that are closest to x2i in terms of meta-data. This also opens up the possibility of learning
wl from some combination of data and meta-data, given a specific study population, and
a specific target score with respect to which to explore heterogeneity. A learning based
approach could possibly do away with parameter selection in CHAMP.
Another possibility for improving the matching procedure would be to devise a high dimen-
sional analog of a point cloud matching algorithm for generating matches. Such an algorithm
could potentially generalize to larger collections of meta-variables and even incorporate im-
age information directly into the matching procedure. Each of these approaches require
extensive experimental verification and consequent modifications to develop into mature
heterogeneity analyses tools. Hence, it presents a promising avenue for future research.
5.2.4. Robustness to scanner and pre-processing variation
In this dissertation, we have presented results using several different datasets. Each of these
datasets was acquired using a scanning protocol unique to it. Image preprocessing pipelines
used also differed between datasets. We suspect that these variations should ultimately
lead to slight variation in the results of the analysis. As such, this type of variation affects
not only the methods presented here but also other well established population based anal-
ysis methods in literature. Addressing the variation in results due to variation in scanner
types/preprocessing protocols is a wide and complex area of research that has not been
broached in this dissertation. However, we have pointed this out here since we believe that
robustness to such variation is an important aspect which needs to be addressed in the
future.
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5.2.5. Extension to other types of data
All the experiments and results presented in this dissertation are focussed on neuroimaging
data. However, high dimension low sample size data appear in several other fields of scien-
tific inquiry as well. For instance assays measuring the difference in expression of thousands
of human genes between a few patients and controls constitute high dimension low sample
size data in genomics. High dimension low sample size datasets may also occur in the field of
natural language processing where they might be used for sentiment analysis. The methods
developed here may be extended and applied in genomics as well as in language processing.
In general they may be applied to any other field of scientific inquiry as long as the base
assumptions underlying these methods can be adapted to the specific application.
5.3. Conclusion
In conclusion, we have presented a high dimensional perspective on population based neu-
roimaging analysis and enumerated several avenues along which our work may be developed
further.
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APPENDIX A
Appendix
A.1. Medical imaging modalities
T1 weighted magnetic resonance imaging (T1): T1 weighted scans are one of the
basic pulse sequences in MRI. Magnetic resonance imaging or (MRI) is ultimately based on
the physical phenomenon called Nuclear magnetic resonance (NMR). Each atomic nucleus
is associated with a quantized set of spin quantum numbers. For instance the hydrogen
nuclei which typically drive the signal in MR imaging can exist in two possible spin states
(m=1/2 and m=-1/2). Normally, these states have the same energy level, that is , they are
degenerate. However, placing them in a strong external magnetic field flips this balance and
aligns the nuclei in one state or the other resulting in a net magnetization vector aligned
with the applied external field. If an electromagnetic pulse corresponding to the energy
difference between the two quantum states is now applied to the tissue, some of the protons
flip causing the net magnetization vector to diverge from the external magnetic field. In
the time after the application of the pulse the magnetization in the direction of the external
field recovers to its original strength. Different tissues require different amounts of time
to complete this recovery. These differences are the source of the T1-weighted MR image
signal. In general tissue containing a higher amount of water, and thus more hydrogen
nuclei, is darker on a T1-weighted image. Fatty tissue on the other hand is brighter in this
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modality. Consequently, myelin sheaths that cover neuronal axons appear brighter and the
cell body of the neuron appears darker.
T2 weighted magnetic resonance imaging (T2) While T1 relies on the decay of lon-
gitudinal magnetization, that is, the component of the magnetization that is aligned with
the external field, a T2 weighted MR image relies on the decay of transverse magnetization.
Transverse magnetization refers to the component of the net magnetization vector that is
perpendicular to the external magnetic field. The pulse sequences used to acquire T2 im-
ages differ from those used to acquire T1 images in that they use longer relaxation and
excitation times. Fatty tissue appears darker of T2 relative to tissue containing a higher
amount of water. A sample T2 image is shown in figure 58.
Proton density images (PD) Another commonly used radiologic imaging modality is
the proton density or PD image. This image is produced by controlling the selection of scan
parameters to minimize the effects of T1 and T2, resulting in an image dependent primarily
on the density of protons in the imaging volume. This image is essentially a quantitative
summary of the number of protons per unit tissue. The higher the number of protons in a
given unit of tissue,the brighter the signal on the proton density contrast image. Conversely
the lower the number of protons in a given unit of tissue, the darker the signal on the proton
density image.
Fluid Attenuated Inversion Recovery (FLAIR)
(FLAIR) Fluid attenuation inversion recovery is a special inversion recovery sequence used
to remove the effects of fluid from the resulting images. For example, it can be used in brain
imaging to suppress signals from cerebrospinal fluid (CSF) in the image, so as to bring out
hyperintense lesions, such as multiple sclerosis (MS) plaques.
Blood oxygen level dependent functional magnetic resonance imaging (BOLD-
fMRI) Neuronal firing in the brain is necessary for any processing task. The energy
required by the neurons for performing these tasks is delivered to them in the form of
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oxyhemoglobin. Neuronal processing involves oxygen exchange resulting in the formation
of deoxyhemoglobin. The degree of magnetization in response to an applied external field
differs between oxyhemoglobin and deoxyhemoglobin. This can be used as a source of signal
in MRI. The measurement of this signal is the source of BOLD fMRI.
Diffusion tensor imaging Diffusion tensor imaging is a method that allows the mapping
of the diffusion process of water molecules in vivo. Molecular diffusion of water in brain
tissue is constrained by neuronal axons that compose white matter fibers. In general, water
diffuses more rapidly along white matter fibers and less rapidly in a direction perpendicular
to them. Therefore, diffusion patterns can reveal white matter fiber structure of the brain.
Diffusion tensor imaging (DTI) is an imaging modality designed to capture this informa-
tion. Advanced tractography algorithms can utilize the information contained in these DTI
images to map white matter tracts in the human brain.
Positron emission tomography (PET) This is an imaging technique based on in vivo
quantification of radioactivity. PET imaging relies on the introduction of a radioactive
tracer based on a biologically active molecule into the body. A prime example of such
a compound is 2-fluoro-2-deoxy-D-glucose (FDG). These compounds are a)differentially
accumulated by specific tissue types and b)they radioactively decay inside the body to
produce positrons. These positrons annihilate electrons inside the body to produce two
gamma ray photons travelling in opposite directions that are detected by the scanner. The
PET imaging system then reconstructs a 3D image of tracer concentration within the body.
Figure 58 shows representative slices from brain images captured using each of the previously
described modalities.
Perfusion imaging Perfusion imaging measures parameters related to the passage of blood
through blood vessels into the brain. These parameters may measure regional cerebral blood
flow, blood volume or oxygenation. In neuroimaging perfusion studies may be done either
with the aid of an external contrast inducing agent such as a gadolinium based agent or with
137
Figure 58: Illustrative slices of brain images captured using different imaging modalities.
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the use of an intrinsic signal inducing phenomenon such as arterial spin labelling. Perfusion
imaging of the brain allows us to study blood flow and is thus a promising tool in assessing
disorders related to changes in blood flow and vascularization. It has shown promise in the
study of stroke, brain tumors, and also in the study of neurodegenerative diseases.
CT scans A computed tomography or CT scan re-constructs the a 3D image of an organ
using a series of radial sections obtained using X-ray imaging. Thus, CT produces a volume
image corresponding to a various anatomical structures in the body based on their respective
ability to block X-rays. Naturally, CT images are most useful for studying skeletal structures
in the body. A brain slice computed using CT is shown in figure 58.
A.2. Image preprocessing techologies
A.2.1. Image enhancement
Often the first step in any image analysis pipeline involves improving the image quality using
tools for image denoising, bias field correction or histogram equalization. As such there
exists a substantial amount of literature on how best each of these steps may be done. For
instance image de-noising often involves smoothing using a specific type of image filtering
algorithm. A widely applied example of such an algorithm is presented in (?). Similarly, N3
bias correction (Sled et al., 1998) is an algorithm that changes voxel intensities to sharpen
tissue peaks. It is commonly used for correcting inhomogeneities for MR images acquired
on account of surface coils (see figure 60). Standard histogram equalization algorithms are
included in toolkits like uch as ITK , MIPAV (McAuliffe et al., 2001) and FSL (Jenkinson
et al., 2012) as well.
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Figure 59: (a) Raw image (b) Image denoised using Gaussian smoothing
Figure 60: (a) PD image with bias (b) PD image after bias correction with n3 (c) bias field
detected by n3
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Figure 61: Illustrative example of the process of skull removal/ brain extraction
A.2.2. Brain extraction
Brain extraction, or skull stripping is a necessary preprocessing step in most neuroimaging
analysis pipelines. It consists of the removal of the skull and the extracerebral tissues
(e.g., scalp and dura) on brain magnetic resonance (MR) images. An illustrative example
of extraction on a T1-weighted image is shown in figure 61. Several alternative methods
for skull stripping are available in literature. One of the most popular approaches is the
BET algorithm implemented as a part of FSL (Smith, 2002). Recent developments in skull
stripping favor the use of learning based multi atlas techniques (Doshi et al., 2013; Lötjönen
et al., 2010) and learning based methods(Iglesias et al., 2011). The data analysis presented
throughout this thesis uses one of these methods, namely the weighted multi atlas skull
stripping (MASS Doshi et al. (2013)) algorithm for brain extraction. To extract a brain
from a given target image, the algorithm first registers a pre-selected set of template brain
images to the target. Each of these template brain images are pre-segmented into brain and
skull manually. A weighted label fusion technique is then used to extract the brain from the
target image. All data processed through this pipeline is manually checked and corrected
for errors if any. After, skull stripping and image enhancement, we obtain a set of relatively
clean brain images. However, in order to compare images across a population, specialized
image processing techniques are needed. Image segmentation and image registration are
the two fundamental concepts that are required to be understood from the group analysis
perspective. These are described next.
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Figure 62: Illustrative example tissue segmentation of MR images into grey matter, white
matter and cerebrospinal fluid
A.2.3. Image segmentation
In general, image segmentation is the partitioning of an image into multiple sets of pixels
(segments), such that the resulting representation is more meaningful than the original
image. The problem of automatic image segmentation has received tremendous attention
from the medical imaging community in the past two decades. Specifically, in the case
of structural brain images, it is used in the context of dividing the image into different
tissue types such as grey matter, white matter and cerebrospinal fluids. There exist several
different segmentation methods that address the task of brain image segmentation. A
detailed review of segmentation methods is unnecessary for the purposes of this thesis.
The adaptive k-means algorithm (Pham and Prince, 1999) and the multiplicative intrinsic
component optimization (MICO) algorithm (Li et al., 2014) are geared towards segmenting
grey matter, white matter and cerebrospinal fluids from adequately preprocessed brain
images . Each of these algorithms perform segmentation by estimating the probability that
a given voxel belongs to a specific tissue type. Sample segmentations of grey and white
matter in the T1-MR image obtained using adaptive k-means are shown by figure 62.
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A.2.4. Image registration
Image registration involves warping different images into a single template co-ordinate sys-
tem so that a voxel by voxel comparison between the different images is meaningful and
interpretable. The concept is illustrated in figure 63. The immense anatomical variation
in human brains makes brain image registration a particularly challenging problem. For a
comprehensive review of the literature of image registration techniques we refer the reader
to a comprehensive review by (Sotiras et al., 2013). Typically, brain image registration
is a two step procedure. Brain images are first transformed into a standardized template
space via a global affine transformation or linear registration. This is followed by non linear
deformations to match the intricate anatomical details between subject and template, also
known as non linear registration. Mapping of a group of subjects to a template in this
manner is an essential element of any large scale neuroimaging study. Without a common
co-ordinate system it would be impossible to quantify the differences and similarities be-
tween different subjects. The template space to which the mapping is made is usually called
an atlas. The atlas, for a particular study may be the brain image of a single subject chosen
from the study, a population average or an independently annotated external image. One
of the oldest such atlases is the Talairach atlas (Talairach and Tournoux, 1988). Another
commonly used template is the population average atlas supplied by the Montreal Neurolog-
ical Institute (MNI). We used an in house template for the analysis presented in this work.
The area of brain image registration has been a particularly active topic of research in the
medical imaging analysis community. Consequently there are several methods starting from
intensity based registration (Collins et al., 1994; Collins and Evans, 1999; Ashburner et al.,
1997), physical model based image registration (Christensen et al., 1997; Davatzikos, 1997;
Gee et al., 1993; Toga, 1998), diffeomorphic frameworks (Vercauteren et al., 2009; Avants
et al., 2008; ?) and the more recent feature vector based registration (Shen and Davatzikos,
2002; Ou et al., 2011). The experiments presented here, use methods presented in (Shen
and Davatzikos, 2002; Ou et al., 2011).
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Figure 63: Concept of image registration
A.2.5. Feature extraction: Tissue density map generation
The registration process described above can yield one deformation field per image in a
population based study. If registration was perfect the deformation field associated with
each subject encodes all the information about the subject anatomy and the registered sub-
ject looks exactly the same as the template image. However, registration is rarely if ever
perfect and the information about subject anatomy encoded in the deformation field alone
is at best partial. Nevertheless, different ways of comparing deformation fields have been
devised in literature. We will go through some of these measures in the literature review
presented in the next section. However, in this section we present the regional analysis
of volumes examined in normalized space (RAVENS) approach, that we use to compare
anatomical information from different subjects. Briefly, for each tissue in the subject brain
(grey matter/white matter/ cerebrospinal fluid) the RAVENS approach generates a tissue
density map (see figure 64) in the template space. To do this the RAVENS analysis asso-
ciates a counter with each location in template space. This counter increments every time
a voxel associated with a specific tissue type in subject space is mapped to the location of
the counter. Ultimately this leads to a tissue density map for each tissue for each subject.
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Figure 64: Illustrative example of tissue density maps
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This allows the registration procedure to be utilized for comparing shape and volume in
a principled manner across a population of images, by simply warping them to a common
template space. The RAVENS approach is volume preserving and encodes shape differ-
ences in subject space as density differences in template space. Since, the map is volume
preserving, every voxel in the subject space is mapped to some voxel in the template space.
Thus, RAVENS maps immediately allow us to establish location correspondence between
different subjects , which translates to feature correspondence in a machine learning set-
ting. RAVENS maps associated with structural data have been widely used in experiments
and analysis presented in this thesis. Hence, we have introduced the concept before the
literature review. We refer the reader to original literature (Davatzikos, 1998; Davatzikos
et al., 2001) for additional details.
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